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(57)	 ABSTRACT
A method of forming an image of a sample includes perform-
ing SOCT on a sample. The sample may include a contrast
agent, which may include an absorbing agent and/or a scat-
tering agent. A method of forming an image of tissue may
include selecting a contrast agent, delivering the contrast
agent to the tissue, acquiring SOCT data from the tissue, and
converting the SOCT data into an image. The contributions to
the SOCT data of an absorbing agent and a scattering agent in
a sample may be quantified separately.
23 Claims, 12 Drawing Sheets
110
Selecting at least one contrast agent
100
Delivering the at least one
	
120
contrast agent to tissue
i
Acquiring SOCT datafrom the	 130
tissue
Converting the SOOT data 	 140




U.S. PATENT DOCUMENTS 7,217,410 B2	 5/2007 Suslick et al.
7,610,074 B2	 10/2009 Boppart et al.
5,505,932 A 4/1996 Grinstaff et al. 2002/0028993 Al 	 3/2002 Hainfeld
5,508,021 A 4/1996 Grinstaff et al. 2002/0054912 Al 	 5/2002 Kim et al.
5,512,268 A 4/1996 Grinstaff et al. 2002/0087071 Al 	 7/2002 Schmitz et al.
5,560,933 A 10/1996 Soon-Shiong et al. 2002/0168161 Al 	 11/2002 Price et al.
5,635,207 A 6/1997 Grinstaff et al. 2003/0045798 Al 	 3/2003 Hular et al.
5,639,473 A 6/1997 Grinstaff et al. 2003/0068496 Al 	 4/2003 Wei et al.
5,648,506 A 7/1997 Desai et al. 2003/0082104 Al 	 5/2003 Mertelmeier
5,650,156 A 7/1997 Grinstaff et al. 2003/0171678 Al 	 9/2003 Batten et al.
5,665,382 A 9/1997 Grinstaff et al. 2004/0015062 Al 	 1/2004 Ntziachristos et al.
5,665,383 A 9/1997 Grinstaff et al. 2004/0023415 Al 	 2/2004 Sokolov et al.
5,752,518 A 5/1998 McGee et al. 2004/0024307 Al 	 2/2004 Golman et al.
5,836,877 A 11/1998 Zavislan 2004/0058458 Al 	 3/2004 Anker et al.
5,891,619 A 4/1999 Zakim et al. 2004/0186359 Al 	 9/2004 Beaudoin et al.
5,914,806 A 6/1999 Gordon, II et al. 2004/0249268 Al 	 12/2004 Da Silva
5,921,926 A 7/1999 Rolland et al. 2005/0004453 Al 	 1/2005 Tearney et al.
5,930,026 A 7/1999 Jacobson et al. 2005/0036150 Al*	 2/2005 Izatt et al .	 ...................	 356/479
5,972,493 A 10/1999 Iwasaki et al. 2005/0078363 Al 	 4/2005 Gugel
5,994,690 A 11/1999 Kulkami et al. 2005/0149002 Al 	 7/2005 Wang et al.
5,995,645 A 11/1999 Soenksen et al. 2005/0168735 Al 	 8/2005 Boppart et al.
6,002,476 A 12/1999 Treado 2005/0171433 Al 	 8/2005 Boppart et al.
6,002,480 A 12/1999 Izatt et al. 2006/0039004 Al 	 2/2006 De Boer et al.
6,037,579 A 3/2000 Chan et al. 2006/0066848 Al 	 3/2006 Frankel
6,068,600 A 5/2000 Johnson et al. 2006/0109478 Al 	 5/2006 Tearney et al.
6,069,932 A 5/2000 Peshkin et al. 2006/0192969 Al 	 8/2006 Marks et al.
6,091,496 A 7/2000 Hill 2006/0281068 Al 	 12/2006 Maier et al.
6,108,081 A 8/2000 Holtom et al. 2006/0292839 Al 	 12/2006 Yi et al.
6,111,645 A 8/2000 Tearney et al. 2007/0203404 Al 	 8/2007 Zysk et al.
6,134,003 A 10/2000 Tearney et al. 2008/0140341 Al 	 6/2008 Ralston et al.
6,151,522 A 11/2000 Alfano et al. 2008/0281205 Al*	 11/2008 Naghavi et al . 	 ............. 600/458
6,156,292 A 12/2000 Quay 2009/0185166 Al 	 7/2009 Oldenburg et al.
6,159,445 A 12/2000 Klaveness et al. 2009/0185191 Al 	 7/2009 Boppart et al.
6,167,297 A 12/2000 Benaron 2009/0221920 Al 	 9/2009 Boppart et al.
6,208,886 B1 3/2001 Alfano et al.
6,219,137 B1 4/2001 Vo-Dinh FOREIGN PATENT DOCUMENTS6,231,834 B1 5/2001 Unger et al.
6,246,892 B1 6/2001 Chance EP	 1 312 912 5/2003
6,246,901 B1 6/2001 Benaron EP	 1 447 043 8/2004
6,249,271 B1 6/2001 Albert et al. EP	 0 963 540 3/2006
6,262,706 B1 7/2001 Albert et al. WO	 WO 90/01697 2/1990
6,262,833 B1 7/2001 Loxley et al. WO	 WO 97/32182 9/1997
6,264,917 B1 7/2001 Klaveness et al. WO	 W098/30873 7/1998
6,264,918 B1 7/2001 Johnson et al. WO	 WO 98/38907 9/1998
6,280,704 B1 8/2001 Schutt et al. WO	 W099/06794 2/1999
6,300,932 B1 10/2001 Albert WO	 W099/58972 11/1999
6,307,633 B1 10/2001 Mandella et al. WO	 WO 00/42906 7/2000
6,307,634 B2 10/2001 Hitzenberger et al. WO	 WO 00/42912 7/2000
6,312,304 B1 11/2001 Duthaler et al. WO	 W002/41760 5/20026,315,981 B1 11/2001 Unger WO	 WO 02/088705 11/20026,344,272 B1 2/2002 Oldenburg et al. WO	 W003/061454 7/20036,363,163 B1 3/2002 Xuetal.
6,428,811 B1 8/2002 West et al. WO	 W02005/028663 3/2005
6,485,413 B1 11/2002 Boppart et al. WO	 W02006/020302 2/2006
6,514,767 B1 2/2003 Natan WO	 W02006/032009 3/2006
6,529,277 B1 3/2003 Weitekamp WO	 W02006/099191 9/2006
6,530,944 B2 3/2003 West et al. WO	 W02006/135628 12/2006
6,538,805 B1 3/2003 Norwood et al. WO	 WO 2007/027194 3/2007
6,539,156 B1 3/2003 Dickson et al. WO	 WO 2007/090147 9/2007
6,560,478 B1 5/2003 Alfano et al. WO	 WO 2008/008774 1/2008
6,564,087 B1 5/2003 Pitris et al.
6,574,401 B2 6/2003 Neuberger et al. OTHER PUBLICATIONS
6,584,335 B1 6/2003 Haar et al.
6,615,063 B1 9/2003 Ntziachristos et al. Sadder et al., "Spherical ensembles of gold nanoparticles on silica:
6,618,423 B1 9/2003 Dekorsy et al. electrostatic and size effects", Chem. Commun., 1604-05, 2002.
6,689,067 B2 2/2004 Sauer et al. Tearney et al., "High-Speed Phase- and Group-Delay Scanning with
6,690,966 B1 2/2004 Rava et al. a Grating-Based Phase Control Delay Line", Optics Letters, vol. 22,
6,795,777 B1 9/2004 Scully et al. No. 23 :1811-1813, 1997.
6,825,928 B2 11/2004 Liu et al. Tearney et al., "In vivo endoscopic optical biopsy with optical coher-
6,839,586 B2 1/2005 Webb ence tomography", Science, 276: 2037-2039, 1997.
6,922,583 BI 7/2005 Perelman et al. Tearney et al., "Rapid acquisition of in vivo biological images by use
7,181,266 B2 2/2007 Frangioni et al. of optical coherence tomography", Optics Letters, 21: 1408-1410,
7,198,777 B2 4/2007 Boppart et al. 1996.
US 7,725,169 B2
Page 3
Tearney et al., "Scanning single-mode fiber optic catheter-endoscope
for optical coherence tomography", Optics Letters, 21: pp. 543-545,
1996.
Templeton et al., "Monolayer-protected cluster molecules", Ace.
Chem. Res., 33:27-36, 2000.
Timmerman et al., "Resorcinarenes" Tetrahedron, 52:2663-704,
1996.
Tkachenko et al., "Multifunctional Gold Nanoparticle-Peptide Com-
plexes for Nuclear Targeting", J. Am. Chem. Soc., 125:4700-4701,
2003.
Wang et al., "Use of a Laser Beam with an Oblique Angle of Inci-
dence to Measure the Reduced Scattering Coefficient of a Turbid
Medium", Applied Optics, 34:2362-2366, 1995.
Webb et al., "Sonochemically produced fluorocarbon microspheres:
a new class of magnetic resonance imaging agent", J. Magnetic
Resonance Imaging, 6:675-683, 1996.
Wei et al., "Resorcinarene-encapsulated nanoparticles: building
blocks for self-assembled nanostructmes", J. Inclusion Phenomenal
Macrocyclic Chemistry, 41, 83-86, 2001.
Wei et al., "Synthesis and Characterization of Resorcinarene-Encap-
sulated Nanoparticles", Mater. Res. Soc., Symp. Proc. Ser., 581:59-
63, 1999.
Wei et al., "Tunable Surface-Enhanced Raman Scattering from Large
Gold Nanoparticle Arrays", ChemPhysChem., 2:743-45, 2001.
Wong et al., "Sonochemically produced hemoglobin microbubbles",
Mat. Res. Soc. Symp. Proc., 372:8994, 1995.
Zaheer et al., "In vivo near-infrared fluorescence imaging of
osteoblastic activity", Nature Biotechnology, 19:1148-54, 2001.
Marks et al., "Interferometric differentiation between resonant
Coherent Anti-Stokes Raman Scattering and nomesonant four-wave-
mixing processes", arXiv:physics/0403007, pp. 1-8, 2004.
Vinegoni et al., "Nonlinear optical contrast enhancement for optical
coherence tomography", Optics Express, vol. 12, No. 2, p. 331-341,
2004.
Kee et al., "Simple approach to one-laser, broadband coherent anti-
Stokes Raman scattering microscopy", Optics Letters, vol. 29, No.
23, p. 2701-2703, 2004.
Kano et al., "Vibrationally resonant imaging of a single living cell by
supercontinuum-based multiplex coherent anti-Stokes Raman scat-
tering microspectroscopy", Optics Express, vol. 13, Issue 4, pp.
1322-1327, 2005.
Gao et al., "Formulation, Characterization, and Sensing Applications
of Transparent Poly(vinyl alcohol)-Polyelectrolyte Blends", Chem.
Mater., 10, pp. 2481-2489, 1998.
Marks et al., Molecular Species Sensitive Optical Coherence
Tomography Using Coherent Anti-Stokes Raman Scattering Spec-
troscopy, Coherence Domain Optical Methods and Optical Coher-
ence Tomography in Biomedicine VII, Proceedings of SPIE, vol.
4956, pp. 9-13, 2003.
Bredfeldt et al., "Non-linear interferometric vibrational imaging",
Conference on Lasers and Electro-optics, CLEO '03, pp. 309-311,
2003.
Vinegoni et al., "Nonlinear optical contrast enhancement for optical
coherence tomography", http://www.arxiv.org/abs/physics/
0312114, 13 pages (2003).
Zumbusch et al., "Three-dimensional vibrational imaging by coher-
ent anti-Stokes Raman scattering", Phys. Rev. Lett., 82(20), pp.
4142-4145, 1999.
Cheng et al., "An epi-detected coherent anti-Stokes Raman scattering
(E-CARS) microscope with high spectral resolution and high sensi-
tivity", J. Phys. Chem, 105(7), pp. 1277-1280, 2001.
Hashimoto et al., "Molecular vibration imaging in the fingerprint
region by use of coherent anti-Stokes Raman scattering microscopy
with a collinear confimation", Opt. Lett., 25(24), pp. 1768-1770,
2000.
Volkmer et al., "Vibrational imaging with high sensitivity via
epidected coherent anti-Stokes Raman scattering microscopy", Phys.
Rev. Lett., 87(2):023901-1-4, 2001.
Fantini et al., "Assessment ofthe size, position, and optical properties
of breast tumors in vivo by noninvasive optical methods", Applied
Optics, vol. 37, pp. 1982-1989, 1998.
Faber et al., "Quantitative measurement of attenuation coefficients of
weakly scattering media using optical coherence tomography",
Optics Express, 12(19), pp. 4353-4365, 2004.
Fujimoto et al., "Optical Coherence Tomography: An Emerging
Technology for Biomedical Imaging and Optical Biopsy",
Neoplasia, 2(1-2), pp. 9-25, 2000.
Zysk et al., "Computational methods for analysis of human breast
tumor tissue in optical coherence tomography images", Journal of
Biomedical Optics, 11(5), 054015-1-054015-7, 2006.
Levitz et al., "Determination of optical scattering properties of
highly-scattering media in optical coherence tomography images",
Optics Express, 12(2), pp. 249-259, 2004.
Morgner et al., "Spectroscopic optical coherence tomography",
Optics Letters, 25(2), pp. 111-113, 2000.
Gossage et al., "Texture analysis of optical coherence tomography
images: feasibility for tissue classification", Journal of Biomedical
Optics, 8(3), pp. 570-575, 2003.
Zvyagin et al., "Refractive index tomography of turbid media by
bifocal optical coherencerefractometry", Optics Express, 11(25), pp.
3503-3517,2003.
Gottschalk, "Ein Mepverfahren zur Bestimmung der optischen
Parameter biologisher Gewebe in vitro", Dissertation 93 HA 8984,
Universiti t Fridericiana Karlsruhe, 1993.
Bolin, F.P. et al., "Refractive index of some mammalian tissues using
a fiber optic cladding method", Applied Optics, 28, pp. 2297-2303,
1989.
Tearney et al., "Determination of the refractive index of highly scat-
tering human tissue by optical coherence tomography", Optics Let-
ters, 20(21), pp. 2258-2260, 1995.
Zysk et al., "Needle-based refractive index measurement using low-
coherence interferometry", Optics Letters, 32, pp. 385-387, 2007.
Zysk et al., "Refractive index of carcinogen-induced rat mammary
tumours", Phys. Med. Biol., 51, pp. 2165-2177,2006.
Li et al., "Measurement method of the refractive index of biotissue by
total internal reflection", Applied Optics, 35, pp. 1793-1795, 1996.
Knuttel et al., "Spatially confined and temporally resolved refractive
index and scattering evaluation in human skin performed with optical
coherence tomography", Journal of Biomedical Optics, 5, pp. 83-92,
2000.
Boppart et al., "Optical coherence tomography: feasibility for basic
research and image-guided surgery of breast cancer", Breast Cancer
Research and Treatment, vol. 84, pp. 85-97, 2004.
Liberman et al., "Palpable breast masses: Is there a role for percutane-
ous image-guided core biopsy?", American Journal of Roentgenol-
ogy, vol. 175, pp. 779-787, 2000.
Bolivar et al., "Stereotaxic core needle aspiration biopsy with mul-
tiple passes in nonpalpable breast lesions", Acta Radiologica, vol. 39,
pp. 389-394, 1998.
Acheson et al., "Histologic correlation of image-guided core biopsy
with excisional biopsy of nonpalpable breast lesions", Archives of
Surgery, vol. 132, pp. 815-821, 1997.
Pijnappel et al., "The diagnostic accuracy of core biopsy in palpable
and non-palpable breast lesions", European Journal of Radiology,
vol. 24, pp. 120-123, 1997.
Durduran et al., "Bulk optical properties of healthy female breast
tissue", Physics in Medicine and Biology, vol. 47, pp. 2847-2861,
2002.
International Search Report dated Feb. 15, 2007 for International
Application No. PCT/US2006/006618, 5 pages.
Marks et al., "Interferometric differentiation between resonant coher-
ent anti-Stokes Raman scattering and nomesonant four-wave-mixing
processes", Applied Physics Letters, vol. 85, No. 23, pp. 5787-5789,
2004.
Marks et al., "Nonlinear Interferometric Vibrational Imaging",
Physical Review Letters, vol. 92, No. 12, pp. 123905-1-123905-4,
2004.
Boppart et al., "Contrast Enhancement Methods for Optical Coher-
ence Tomography", Biophotonics/Optical Interconnects and VLSI
Photonics/WBM Microactivities, 2004 Digest of the Leos Summer
Topical Meetings, San Diego, CA, pp. 14-15, 2004.
Marks et al., "Pulse Shaping Strategies for Nonlinear Interferometric
Vibrational Imaging Optimized for Biomolecular Imaging", Pro-
US 7,725,169 B2
Page 4
ceedings of the 26 `h Annual International Conference of the IEEE
EMBS, San Francisco, CA, pp. 5300-5303, 2004.
Bredfeldt et al., "Nonlinear interferometric vibrational imaging of
molecular species", Proc. Of SPIE, vol. 5321, pp. 149-156, 2004.
Easy Core Biopsy System, Product Brochure, Boston Scientific, 5
pages, 2004.
Yodh et al., "Spectroscopy and Imaging with Diffusing Light," Phys-
ics Today, pp. 34-40, 1995.
Roggan et al., in "Laser Induced Interstitial Thermotherapy", Muller,
Ed., pp. 39-40,43, 1995.
Ohmi et al., "In Vitro Simultaneous Measurement of Refractive Index
and Thickness of Biological Tissue by the Low Coherence
Interferometry", IEEE Transactions on Biomedical Engineering, vol.
47, No. 9, pp. 1266-1270, 2000.
Luo et al., "Optical Biopsy of Lymph Node Morphology using Opti-
cal Coherence Tomography", Technology in Cancer Research &
Treatment, vol. 4, No. 5, pp. 539-547, 2005.
Dehghani et al., "The effects of internal refractive index variation in
near-infrared optical tomography: a finite element modelling
approach", Physics in Medicine and Biology, 48, pp. 2713-2727,
2003.
Schmitt et al., "Turbulent nature of refractive-index variations in
biological tissue", Optics Letters, vol. 21, No. 16, pp. 1310-1312,
1996.
Zysk et al., "Projected index computed tomography", Optics Letters,
vol. 28, No. 9, pp. 701-703, 2003.
Easy Core Biopsy System, Product Brochure, Boston Scientific, 4
pages, 2004.
Evans et al., "Coherent anti-Stokes Raman scattering spectral
interferometry: determination of the real and imaginary components
of nonlinear susceptibility chi(3) for vibrational microscopy", Optics
Letters, vol. 29, No. 24, pp. 2923-2925, 2004.
Yoon et al., "Dependence of line shapes in femtosecond broadband
stimulated Raman spectroscopy on pump-probe timed delay", J
Chem Phys., 122(2), p. 024505, 2005, 20 pages.
Kolomoitsev et al., "New problems of femtosecond time-domain
CARS of large molecules", SPIE vol. 1402, pp. 31-43, 1990.
Mehendale et al, "Towards an anthrax detector using the femtosecond
adaptive spectroscopic technique for coherent anti-Stokes Raman
Spectroscopy: coherent anti-Stokes Raman spectroscopy signal from
dipicolinic acid in bacterial spores", Journal of Modern Optics, vol.
51, pp. 2645-2653, 2004.
Ai et al., "Electrostatic layer-by-layer nanoassembly on biological
microtemplates: platelets", Biomacromolecules, 3:560-564, 2002.
Amsden et al., "An examination of factors affecting the size, distri-
bution, and release characteristics of polymer microbeads made
using electrostatics", J. Control. Release, 43:183-196, 1997.
Amsden, "The production of uniformly sized polymer
microspheres", Pharm. Res., 16:1140-1143, 1999.
Balasubramanian et al., "Extraction and dispersion of large gold
nanoparticles in nonpolar solvents", J. Dispers. Sci. Tech. 22:485-89,
2001.
Balasubramanian et al., "Dispersion and stability studies of
resorcinarene-encapsulated gold nanoparticles", Langmuir,
18:3676-81, 2002.
Barton et al., "Use of microbubbles as an optical coherence
tomography contrast agent", Acad. Radiol, 9, (Suppl 1):552-555,
2002.
Blackwell et al., "New approaches to olefin cross-metathesis", J. Am.
Chem. Soc., 122:58-71, 2000.
Boppart et al., "Imaging Developing Neural Morphology Using Opti-
cal Coherence Tomography", J. Neuroscience Methods, vol. 70, pp.
65-72, 1996.
Boppart at al., "Investigation of Developing Embryonic Morphology
Using Optical Coherence Tomography", Developmental Biology,
vol. 177, pp. 54-63, 1996.
Boppart et al., "Noninvasive assessment of the developing Xenopus
cardiovascular system using optical coherence tomography", Proc.
Nad. Acad. Sci. USA, 94: 4256-4261, 1997.
Boppart et al., "Forward-Imaging Instruments for Optical Coherence
Tomography", Optics Letters, vol. 22, No. 21, pp. 1618-1620, 1997.
Boppart et al., "In vivo Cellular Optical Coherence Tomography
Imaging", Nature Medicine, vol. 4, No. 7, pp. 861-865, 1998.
Boppart et al., "Intraoperative Assessment of Microsurgery with
Three-Dimensional Optical Coherence Tomography", Radiology,
vol. 208, pp. 81-86, 1998.
Boppart et al., "Optical Coherence Tomography for Neurosurgical
Imaging of Human Intracortical Melanoma", Neurosurgery, vol. 43,
No. 4, pp. 834-841, 1998.
Boppart, "Surgical Diagnostics, Guidance, and Intervention Using
Optical Coherence Tomography", Ph.D. Thesis, Massachusetts Insti-
tute of Technology, Cambridge, MA, 226 pages, 1998.
Boppart et al., "High-Resolution Optical Coherence Tomography-
Guided Laser Ablation of Surgical Tissue", J. Surgical Research,
82:275-84, 1999.
Boppart, "Endoscopic Optical Coherence Tomography Imaging of
Barrett's Esophagus", M.D. Thesis, Harvard University, 2000.
Bouma et al., "High resolution optical coherence tomographic imag-
ing using a mode-locked Ti:A'20, laser source", Optics Letter,
20:1486-1488, 1995.
Bouma et al., "High-resolution imaging of the human esophagus and
stomach in vivo using optical coherence tomography",
Gastrointestinal Endoscopy, 51: 467-474, 2000.
Boyer et al., "Photothermal Imaging of Nanometer-Sized Metal Par-
ticles Among Scatterers", Science, 297:1160-63, 2002.
Brezinski et al., "Optical Coherence Tomography for Optical Biopsy:
Properties and Demonstration of Vascular Pathology", Circulation,
vol. 93, pp. 1206-1213, 1996.
Bugaj et al., "Novel fluorescent contrast agents for optical imaging of
in vivo tumors based on a receptor-targeted dye-peptide conjugate
platform", J. Biomedical Optics, 6:122-33, 2001.
Burns et al., "Tumor-localizing and photosensitizing properties of
hematoporphyrin derivative in hamster buccal pouch carcinoma",
Oral Surg. Oral Med, Oral Pathol., 61:368-372, 1986.
Cain et al., "Thresholds for Visible Lesions in the Primate Eye Pro-
duced by Ultrashort Near-Infrared Laser Pulses", Investigative Oph-
thalmology & Visual Science, 40:2343-49, 1999.
Cain et al., "Visible Retinal Lesions from Ultrashort Laser Pulses in
the Primate Eye", Investigative Ophthalmology & Visual Science,
36:879-888, 1995.
Caruso et al., "Nanoengineering of inorganic and hybrid hollow
spheres by colloidal templating", Science, 282:1111-1114, 1998.
Cepak et al., "Preparation and Stability of Template-Synthesized
Metal Nanorod Sols in Organic Solvents", J. Phys. Chem. B,
102:9985-90,1998.
Chen et al., "Noninvasive Imaging of in Vivo Blood Flow Velocity
Using Optical Doppler Tomography", Optics Letters, vol. 22, pp.
1119-1121, 1997.
Christiansen et al., "Physical and biochemical characterization of
Albunexrm, a new ultrasound contrast agent consisting of air-filled
albumin microparticles suspended in a solution of human albumin",
Biotechnol. Appl. Biochem., 19:307-20, 1994.
Clark et al., "Second harmonic generation properties of fluorescent
polymer-encapsulated gold nanoparticles", J. Am. Chem. Soc.,
122:10234-35, 2000.
de Boer et al., "Two-Dimensional Birefringence Imaging in Biologi-
cal Tissue by Polarization-Sensitive Optical Coherence
Tomography", Optics Letters, vol. 22, pp. 934-936, 1997.
Decher "Fuzzy Nanoassemblies: Toward Layered Polymeric
Multicomposites", Science, 277:1232-1237, 1997.
Desai et al., "Controlled and targeted drug delivery with biocompat-
ible protein shell microspheres", 20th Annual Meeting of Society of
Biomaterials, Apr. 4-9, 1994, Boston, MA: Proc. Soc. Biomaterial,
20:112, 1994.
Dick et al., "Computed tomography of experimental liver abscesses
using a new liposomal contrast agent", Investigative Radiology,
31:194-203, 1996.
Dowlatshahi et al., "Histologic Evaluation of Rat Mammary Tumor
Necrosis by Interstitial Nd:YAG Laser Hyperthermia", Lasers in
Surgery and Medicine, 12:159-164, 1992.
Drexler et al., "In vivo Ultrahigh-Resolution Optical Coherence
Tomography", Optics Letters, vol. 24, No. 17, pp. 1221-1223, 1999.
El-Sayed "Some interesting properties ofinetals confined in time and




Freeman et al., "Self-Assembled Metal Colloid Monolayers: An
Approach to SERS Substrates", Science, 267:1629-1632, 1995.
Fu et al., "Visual evidence of acidic environment within degrading
poly(lactic-co-glycolic acid) (PLGA) microspheres", Pharmaceuti-
cal Research, 17:100-106, 2000.
Fujimoto et al., "Optical biopsy and imaging using optical coherence
tomography", Nature Medicine, 1:970-972, 1995.
Gazelle et al., "Nanoparticulate computed tomography contrast
agents for blood pool and liver-spleen imaging", Acad. Radiol.,
1:373-376, 1994.
Geny et al., "Safety of a new transpulmonary echocontrast agent
(Albunex®) in repeated echocardiographic studies in patients", Clin.
Cardiol., 20:111-115, 1997.
Gimenez-Conti et al., "The hamster cheek pouch carcinogenesis
model", J. Cellular Biochemistry Supplement, 17F:83-90, 1993.
Gram, "Drug absorption and distribution", in Modern Pharmacology
with Clinical Applications 5`h Ed., Craig et al., eds., Little, Brown, &
Co., Inc.; Boston, MA, pp. 13-24, 1997.
Grinstaff et al., "Air-filled proteinaceous microbubbles: synthesis of
an echo-contrast agent", Proc. Nad. Acad. Sci. USA, 88:7708-7710,
1991.
Grubbs et al., "Ring-Closing Metathesis and Related Processes in
Organic Synthesis", Ace. Chem. Res., 28:446-52, 1995.
Haes et al., "A nanoscale optical biosensor: sensitivity and selectivity
of an approach based on the localized surface plasmon resonance
spectroscopy of triangular silver nanoparticles", J. Am. Chem. Soc.,
124:10596-604, 2002.
Handley et al., "Colloidal gold labeling studies related to vascular
and endothelial function, hemostasis and receptor-mediatedprocess-
ing of plasma macromolecules", European J. Cell Biology, 43:163-
74, 1987.
Handley et al., "Colloidal gold-low density lipoprotein conjugates as
membrane receptor probes", Proc. Nad. Acad. Sci. USA, 78:368-71,
1981.
Handley "Methods for Synthesis of Colloidal Gold", Colloidal Gold:
Principles, Methods, and Applications, (Academic Press), vol. 1, pp.
13-32,1989.
Hardikar et al., "Coating of nanosize silver particles with silica", J.
Colloid and Interface Science, 221:133-36, 2000.
Harrington et al., "Gene therapy for prostate cancer: current status
and future prospects", J. Urology, 166:1220-33, 2001.
Hartl et al., "Ultrahigh-Resolution Optical Coherence Tomography
Using Continuum Generation in an Air-Silica Microstructure Optical
Fiber", Optics Letters, 26:608-610, 2001.
Hee et al., "Optical coherence tomography of the human retina",
Arch. Ophthalmol. 113: 325-332, 1995.
Hiergeist et al., "Application of magnetite ferrofluids for
hyperthermia", J. Magnetism and Magnetic Materials, 201:420-22,
1999.
Hirsch et al., "A Whole Blood Immunoassay Using Gold
Nanoshells", Analytical Chemistry, 75:2377-2381, 2003.
Huang et al., "Optical Coherence Tomography", Science, 254: 1178-
1181, 1991.
Jackson et al., "Silver Nano shells: Variations in Morphologies and
Optical Properties", J. Phys. Chem. B, 105:2743-46, 2001.
Jana et al., "Wet chemical synthesis of high aspect ratio cylindrical
gold nanorods", J. Phys. Chem. B, 105:4065-67, 2001.
Jang et al„ "Visualization of Coronary Atherosclerotic Plaques in
Patients Using Optical Coherence Tomography: Comparison With
Intravascular Ultrasound", J. American College of Cardiology,
39:604-609,2002.
Jensen et al., "Electrodynamics of noble metal nanoparticles and
nanoparticle clusters", J. Cluster Science, 10:295-317, 1999.
Jin et al., "Photoinduced conversion of silver nanospheres to
nanoprisms", Science, 294:1901-03, 2001.
Jordan et al., "Magnetic fluid hyperthermia (MFH): Cancer treatment
with AC magnetic field induced excitation of biocompatible
superparamagnetic nanoparticles", Magnetism and Magnetic Mate-
rials., 201:413-19, 1999.
Jue et al., "Addition of sulfhydryl groups to Escherichia coli
ribosomes by protein modification with 2-iminothiolane (methyl
4-mercaptobutyrimidate)", Biochemistry, 17:5399-5406, 1978.
Kempka et al., `Binding, uptake, and transcytosis of ligands for
mannose-specific receptors in rat liver: an electron microscopic
study", Experimental Cell Research, 176, 38-48, 1988.
Keye et al., "Argon Laser Therapy of Endometriosis: A Review of 92
Consecutive Patients" Fertility and Sterility, 47:208-212, 1987.
Kim et al., "Hollow silica spheres of controlled size and porosity by
sol-gel processing", J. Am. Ceram. Soc., 74:1987-1992, 1991.
Kim et al., "Photochemical synthesis of gold nanorods" J. Am. Chem.
Soc., 124:14316-17, 2002.
Kim et al., "Self-Organization of Large Gold Nanoparticle Arrays", J.
Am. Chem. Soc., 123:7955-56, 2001.
Kim et al., "Fabrication of hollow silica aerogel spheres by a droplet
generation method and sol-gel processing" J. Vac. Sci., Technol. A.,
7:1181-1184, 1989.
Kneipp at al., "Ultrasensitive Chemical Analysis by Raman Spec-
troscopy", Chem. Rev., 99:2957-75, 1999.
Kolb-Bachofen et al., "Electron microscopic evidence for an
asialoglycoprotein receptor on Kupffer cells: localization of lectin-
mediated endocytosis", Cell, 29:859-66, 1982.
Kolbeck, "The biomedical applications of protein microspheres",
Ph.D. Doctoral Thesis, University of Illinois, Urbana-Champaign,
title page and pp. 153, 159-160, 1999.
Korbelik et al., "Photofrin accumulation in malignant and host cell
populations of various tumours", British Journal of Cancer, 73:506-
513, 1996.
Langer "Drug delivery and targeting", Nature, 392:5-10, 1998.
Larson et al., "Water-Soluble Quantum Dots for Multiphoton Fluo-
rescence Imaging in Vivo", Science, 300:1434-1436, 2003.
Lasic et al., "Liposomes revisited", Science, 267:1275-1276, 1995.
Lee et al., "Delivery of liposomes into cultured KB cells via folate
receptor-mediated endocytosis", J. Biological Chemistry, 269:3198-
3204, 1994.
Lee et al., "Engineered microsphere contrast agents for optical coher-
ence tomography", Optics Letters, vol. 28, No. 17, pp. 1546-1548,
2003.
Lee et al., "Optical Characterization of Contrast Agents for Optical
Coherence Tomography", Proceedings of SPIE, vol. 4967, pp. 129-
134, 2003.
Leelarasamee et al., "A method for the preparation of polylactic acid
microcapsules of controlled particle size and drug loading", J.
Microencapsulation, 5:147-157, 1988.
Leitgeb et al., "Spectral measurement of absorption by spectroscopic
frequency-domain optical coherence tomography", Optics Letters,
25:820-22, 2000.
Li et al., "Optical Coherence Tomography: Advanced Technology for
the Endoscopic imaging of Barrett's Esophagus", Endoscopy, vol.
32, pp. 921-930, 2000.
Li et al., "Imaging Needle for Optical Coherence Tomography",
Optics Letters, 25:1520-1522, 2000.
Li et al., "On the growth of highly ordered pores in anodized alumi-
num oxide", Chem. Mater., 10:2470-80,1998.
Li et al., "Polycrystalline nanopore arrays with hexagonal ordering
on aluminum", J. Vac. Sci. Technol. A, 17:1428-31, 1999.
Licha, "Contrast agents for optical imaging", Topics in Current
Chemistry, 222:1-29, 2002.
Lin et al. "Measurement of tissue optical properties by the use of
oblique-incidence optical fiber reflectometry", Applied Optics,
36:136-43, 1997.
Lin et al., "Intraocular Microsurgery with a Picosecond Nd:YAG
Laser", Lasers in Surgery and Medicine, 15:44-53, 1994.
Liu et al., "In vivo measurement of oxygen concentration using
sonochemically synthesized microspheres", Biophysical J., 67:896-
901, 1994.
Liu et al., "A novel two-step silica-coating process for engineering
magnetic nanocomposites", Chem. Mater., 10:3936-40, 1998.
Liz-Marzan et al., "Homogeneous silica coating ofvitreophobic col-
loids", Chem. Commun., 731-32, 1996.
Lvov et al., "Nanoparticle/polyion assembly on microtemplates




Lvov et al., "Thin film nanofabrication via layer-by-layer adsorption
of tubule halloysite, spherical silica, proteins and polycations", Col-
loids and Surfaces A: Physicohem. Eng. Aspects, 198-200:375-382,
2002.
Marks et al., Nonlinear interferometric vibrational imaging,
E-printgarxiv.org/physics/0311071,  URL http://www.arxiv.org/
abs/physics/0311071, pp. 1-5, 2003.
Marks et al., "Study of an Ultrahigh-Numerical-Aperture Fiber Con-
tinuum Generation Source for Optical Coherence Tomography",
Optics Letters, 27:2010-2012, 2002.
Marks et al., "Pulse shaping strategies for nonlinear interferometric
vibrational imaging optimized for biomolecular imaging", Confer-
ence Proceeding: EMBC 2004: 26th Annual International Confer-
ence of the Engineering in Medicine and Biology Society (Sep. 1-5,
2004, San Francisco, CA), vol. 2, pp. 5300-5303 (accession No.
8255487).
Masuda et al., "Ordered metal nanohole arrays made by a two-step
replication of honeycomb structures of anodic alumina", Science,
268:1466-68, 1995.
Mathias et al., "Tumor-selective radiopharmaceutical targeting via
receptor-mediated endocytosis of Gallium-67-deferoxamine-folate",
J. of Nuclear Medicine, 37:1003-1008, 1996.
McNamara III et al., "Sonoluminescence temperatures during multi-
bubble cavitation", Nature, 401:772-775,1999.
Micali et al., "Separation of Scattering and Absorption Contributions
in UV/Visible Spectra of Resonant Systems", Anal. Chem., 73:4958-
63, 2001.
Minton et al., "The Laser in Surgery. A 23 Year Perspective.", Ameri-
can Journal of Surgery, 151:725-729, 1986.
Mock at al., "Composite plasmon resonant nanowires", Nano Letters,
2:465-69, 2002.
Mock et al., "Shape effects in plasmon resonance of individual col-
loidal silver nanoparticies", J. Chem. Phys., 116:6755-59, 2002.
Mohwald, "From Langmuir monolayers to nanocapsules", Colloids
and Surfaces A: Physicochem. Eng. Aspects, 171:25-31, 2000.
Morgner et al., "Spectrosopic optical coherence tomography", Optics
Letters, 25:111-13, 2000.
Nicewarner-Pena et al. "Submicrometermetallic barcodes", Science,
294:137-41, 2001.
Nielsch et al., "Self-ordering regimes of porous alumina: the 10%
porosity rule", Nano Letters 2:677-80, 2002.
Novak et al., "Purification of molecularly bridged metallic
nanoparticle arrays by centrifugation and size exclusion chromatog-
raphy", Anal. Chem., 73:5758-61, 2001.
Oldenburg et al., "Light Scattering From Dipole and Quadrupole
Nanoshell Antennas", Appl. Phys. Lett., 75:1063-65, 1999.
Pasternack et al., "Resonance Light Scattering: A New Technique for
Studying Chromophore Aggregation", Science, 269:935-39, 1995.
Pathak et al., "Detection of squamous neoplasia by fluorescence
imaging comparing porfimer sodium fluorescence to tissue
autofluorescence in the hamster cheek-pouch model", American
Journal of Surgery, 170:423-426, 1995.
Peters, All about Albumin, in Biochemistry, Genetics, and Medical
Applications, (Academic Press, NewYork), p. 46, 1996.
Pinkerton et al., "Aerosolized fluorescent microspheres detected in
the lung using confocal scanning laser microscopy", Microscopy
Research and Technique, 26:437-443, 1993.
Pitris et al., "High-resolution imaging of gynecologic neoplasms
using optical coherence tomography", Obstetrics & Gynecology, 93:
135-139, 1999.
Pitris et al., "Feasibility of optical coherence tomography for high-
resolution imaging of human gastrointestinal tract malignancies", J.
Gastroenterol., 35: 87-92, 2000.
Pollack et al., "Circumferential Argon Laser Photocoagulation for
Prevention of Retinal Detachment", Eye, vol. 8, pp. 419-422, 1994.
Profio et al., "Transport of light in tissue in photodynamic therapy",
Photochemistry and Photobiology, 46: 591-599, 1987.
Prudhomme et al., "Interstitial Diode Laser Hyperthermia in the
Treatment of Subcutaneous Tumor", Lasers in Surgery and Medi-
cine, 19:445-450, 1996.
Puliafito et al., "Imaging of macular disease with optical coherence
tomography", Ophthalmology, 102: 217-229, 1995.
Puliafito et al., "Optical Coherence Tomography of Ocular Dis-
eases", Slack Inc, Thorofare, N.J., pp. 3-34, 369-374, 1995.
Pusztay et al., "Encagement of Gold Nanoclusters in Crosslinked
Resorcinarene Shells", Supramolecular Chemistry, 14:291-94, 2002.
Quaroni et al., "Preparation of Polymer-Coated Functionalized Sil-
ver Nanoparticles", J. Am. Chem. Soc., 121:10642-43, 1999.
Russell-Jones, "Use of vitamin B 12 conjugates to deliver protein
drugs by the oral route", Critical Reviews in Therapuetic Drug Car-
rier Systems, vol. 15, No. 6, pp. 557-586, 1998.
Sadder et al., "Spherical ensembles of gold nanoparticles on silica:
electrostatic and size effects", Chem. Commun., 1604-05, 2002.
Sansdrap et al., "Influence of manufacturing parameters on the size
characteristics and the release profiles of nifedipine from poly(DL-
lactide-co-glycolide) microspheres", International Journal of
Pharmaceutics, 98:157-164, 1993.
Schaefer et al., "Real-Time Digital Signal Processing-Based Optical
Coherence Tomography and Doppler Optical Coherence
Tomography", IEEE Transactions on Biomedical Engineering, vol.
51, No. 1, pp. 186-190, 2004.
Schaefer "Real-Time, Digital Signal Processing-Based Optical
Coherence Tomography and Optical Doppler Tomography", Master
Thesis, University of Illinois at Urbana-Champaign, 2001.
Schmitt et al., "Measurement of Optical Properties of Biological
Tissues by Low-Coherence Reflectometry", Applied Optics., vol. 32,
pp. 6032-6042, 1993.
Schmitt et al., "Subsurface Imaging of Living Skin with Optical
Coherence Microscopy", Dermatology, vol. 191, pp. 93-98, 1995.
Schmitt et al., "Optical-coherence tomography of a dense tissue:
statistics of attenuation and backscattering", Phys. Med. Biol., 39:
1705-1720,1994.
Sergeev et al., "In vivo endoscopic OCT imaging of precancer and
cancer states ofhuman mucosa", Optics Express, 1: 432-440, 1997.
Sevick-Muraca et al., "Fluorescence-enhanced, near infrared diag-
nostic imaging with contrast agents", Current Opinion in Chemical
Biology, Op. Chem. Biol., 6:642-50,2002.
Shiga et al., "Preparation of Poly(D,L-lactide) and Copoly(lactide-
glycolide) Microspheres of Uniform Size", J. Pharm. Pharmacol.,
48:891-895, 1996.
Shipway et al., "Nanoparticle arrays on surfaces for electronic, opti-
cal, and sensor applications", ChemPhysChem., 1:18-52, 2000.
Sivak Jr. et al., "High-resolution endoscopic imaging of the GI tract
using optical coherence tomography", Gastrointestional Endoscopy,
51:474-479, 2000.
Slaga et al., "An animal model for oral cancer", J. National Cancer
Institute Monographs, 13:55-60, 1992.
Sokolov et al., "Real-Time Vital Optical Imaging of Precancer Using
Anti-Epidermal Growth Factor Receptor Antibodies Conjugated to
Gold Nanoparticles", Cancer Research, 63:1999-2004, 2003.
S6nnichsen et al., "Drastic reduction of plasmon damping in gold
nanorods", Physical Review Letters, vol. 88, No. 7:077402-1 to
077402-4, 2002.
S6nnichsen et al., "Spectroscopy of Single Metallic Nanoparticles
Using Total Internal Reflection Microscopy", Appl. Phys. Lett.,
77:2949-51, 2000.
Stavens et al., "Encapsulation of Neutral Gold Nanoclusters by
Resorcinarenes", Langmuir, 15:8337-39, 1999.
Su et al., "Tumor characterization with dynamic contrast-enhanced
MRI using MR contrast agents of various molecular weights", Mag-
netic Resonance in Medicine, 39:259-269, 1998.
Suslick et al., "Protein Microencapsulation ofNonaqueous Liquids",
J. Am. Chem. Soc., 112:7807-7809, 1990.
Suslick et al., "Versatile sonochemical reaction vessels" in Experi-
mental Organometallic Chemistry: A Practicum in Synthesis and
Characterization, (A. Wayda, Darensburg MY, eds. ACS Symposium
Series, Washington, D.C.), pp. 195-197, 1987.
Suslick, "Sonochemistry", Science, 247: 1439-1445, 1990.
Tanaka et al., "Direct visualization of colloidal gold-bound mol-
ecules and a cell-surface receptor by ultrahigh-resolution scanning
electron microscopy", J. Microscopy, 161:455-61, 1991.
Tearney et al., "Optical Biopsy in Human Gastrointestinal Tissue
Using Optical Coherence Tomography", American Journal of
Gastroenterlogy, vol. 92, pp. 1800-1804, 1997.
US 7,725,169 B2
Page 7
Tearney et al., "Optical Biopsy in Human Urologic Tissue Using
Optical Coherence Tomography", J. Urology, vol. 157, pp. 1915-
1919, 1997.
Tearney et al., "Catheter-based optical imaging of a human coronary
artery", Circulation, 94: 3013, 1996.
Tearney et al., "High-Speed Phase- and Group-Delay Scanning with
a Grating-Based Phase Control Delay Line", Optics Letters, vol. 22,
No. 23 :1811-1813, 1997.
Tearney et al., "In vivo endoscopic optical biopsy with optical coher-
ence tomography", Science, 276: 2037-2039, 1997.
Tearney et al., "Rapid acquisition of in vivo biological images by use
of optical coherence tomography", Optics Letters, 21: 1408-1410,
1996.
Tearney et al., "Scanning single-mode fiber optic catheter-endoscope
for optical coherence tomography", Optics Letters, 21: pp. 543-545,
1996.
Templeton et al., "Monolayer-protected cluster molecules", Ace.
Chem. Res., 33:27-36, 2000.
Timmerman et al., "Resorcinarenes" Tetrahedron, 52:2663-704,
1996.
Tkachenko et al., "Multifunctional Gold Nanoparticle-Peptide Com-
plexes for Nuclear Targeting", J. Am. Chem. Soc., 125:4700-4701,
2003.
Toth et al., "Retinal effects of ultrashort laser pulses in the rabbit eye",
Investigative Ophthalmology & Visual Science, 36:1910-17, 1995.
Toublan et al., "Magnetically-inducible optical contrast agents for
optical coherence tomography", presented at the Optical Society of
America Biomedical Topical Meeting, Miami, FL, Apr. 7-10, 2002.
Tripp et al., "Self-assembly of cobalt nanoparticle rings", J. Am.
Chem. Soc., 124:7914-15, 2002.
Turkevich et al., "A Study of the Nucleation and Growth Processes in
the Synthesis of Colloidal Gold", Faraday Soc., 11:55-75, 1951.
Turing, "The immunology of cutaneous DNA immunization", Cur-
rent Opinion in Molecular Therapeutics, vol. 1, No. 2, pp. 216-225,
1999.
Ung et al., "Controlled method for silica coating of silver colloids.
Influence of coating on the rate of chemical reactions", Langmuir,
14:3740-48, 1998.
van der Laan et al., "In vitro activity of novel antifolates against
human squamous carcinoma cell lines of the head and neck with
inherent resistance to methotrexate", Int. J. Cancer, 51:909-914,
1992.
Van Der Smissen et al., "Ligand-induced clustering of
asialoglycoprotein receptors on rat hepatocytes at 4° C", European J.
of Cell Biology, 60:122-30, 1993.
Van Der Smissen et al., "Quantitative analysis of clustering on bio-
logical membranes: methodology and application to ligand-induced
asialoglycoprotein receptor redistribution on rat hepatocytes", Euro-
pean J. of Cell Biology, 69:45-54, 1996.
van der Zande et al., "Colloidal dispersions of gold rods: synthesis
and optical properties", Langmuir, 16:451-58, 2000.
Violante et al., "Improved detectability of VX2 carcinoma in the
rabbit liver with contrast enhancement in computed tomography",
Radiology, 134:237-239, 1980.
Vitkin et al., "Optical and thermal characterization of natural (Sepia
oficinalis) melanin", Photochemistry and Photobiology, 59:455-62,
1994.
Vo-Dinh, "Surface-Enhanced Raman Spectroscopy Using Metallic
Nanostructures", Trends in Analytical Chemistry, 17:557-82, 1998.
Wang et al., "Semiconductor quantum dot-labeled microsphere
bioconjugates prepared by stepwise self-assembly", Nano Lett.,
2:857-861,2002.
Wang et al., "Use of a Laser Beam with an Oblique Angle of Inci-
dence to Measure the Reduced Scattering Coefficient of a Turbid
Medium", Applied Optics, 34:2362-2366, 1995.
Webb et al., "Sonochemically produced fluorocarbon microspheres:
a new class of magnetic resonance imaging agent", J. Magnetic
Resonance Imaging, 6:675-683, 1996.
Wei et al., "Resorcinarene-encapsulated nanoparticles: building
blocks for self-assembled nanostructures", J. Inclusion Phenomenal
Macrocyclic Chemistry, 41, 83-86, 2001.
Wei et al., "Synthesis and Characterization of Resorcinarene-Encap-
sulated Nanoparticles", Mater. Res. Soc., Symp. Proc. Ser., 581:59-
63, 1999.
Wei et al., "Tunable Surface-Enhanced Raman Scattering from Large
Gold Nanoparticle Arrays", ChemPhysChem., 2:743-45, 2001.
Wong et al., "Sonochemically produced hemoglobin microbubbles",
Mat. Res. Soc. Symp. Proc., 372:89-94, 1995.
Xu et al., "Electromagnetic Contributions to Single-Molecule Sen-
sitivity in Surface-Enhanced Raman Scattering", Physical Review E,
62:4318-24, 2000.
Yazdanfar et al., "High Resolution Imaging of in vivo Cardiac
Dynamics Using Color Doppler Optical Coherence Tomography",
Optics Express, vol. 1, pp. 424-431, 1997.
Yguerabide et al., "Light-scattering submicroscopic particles as
highly fluorescent analogs and their use as tracer labels in clinical and
biological applications", Analytical Biochemistry, 262:137-56,
1998.
Yu et al., "Gold nanorods: electrochemical synthesis and optical
properties", J. Phys. Chem. B, 101:6661-64, 1997.
Zaheer et al., "In vivo near-infrared fluorescence imaging of
osteoblastic activity", Nature Biotechnology, 19:1148-54, 2001.
Marks et al., "Interferometric differentiation between resonant
Coherent Anti-Stokes Raman Scattering and nomesonant four-wave-
mixing processes", arXiv: physic s/0403 007, pp. 1-8, 2004.
Vinegoni et al., "Nonlinear optical contrast enhancement for optical
coherence tomography", Optics Express, vol. 12, No. 2, p. 331-341,
2004.
Kee et al., "Simple approach to one-laser, broadband coherent anti-
Stokes Raman scattering microscopy", Optics Letters, vol. 29, No.
23, p. 2701-2703, 2004.
Kano et al., "Vibrationally resonant imaging of a single living cell by
supercontinuum-based multiplex coherent anti-Stokes Raman scat-
tering micro spectroscopy", Optics Express, vol. 13, Issue 4, pp.
1322-1327, 2005.
Gao et al., "Formulation, Characterization, and Sensing Applications
of Transparent Poly(vinyl alcohol)-Polyelectrolyte Blends", Chem.
Mater., 10, pp. 2481-2489, 1998.
Marks et al., Molecular Species Sensitive Optical Coherence
Tomography Using Coherent Anti-Stokes Raman Scattering Spec-
troscopy, Coherence Domain Optical Methods and Optical Coher-
ence Tomography in Biomedicine VII, Proceedings of SPIE, vol.
4956, pp. 9-13, 2003.
Bredfeldt et al., "Non-linear interferometric vibrational imaging",
Conference on Lasers and Electro-optics, CLEO '03, pp. 309-311,
2003.
Vinegoni et al., "Nonlinear optical contrast enhancement for optical
coherence tomography", http://www.arxiv.org/abs/physics/
0312114, 13 pages (2003).
Zumbusch et al., "Three-dimensional vibrational imaging by coher-
ent anti-Stokes Raman scattering", Phys. Rev. Lett., 82(20), pp.
4142-4145, 1999.
Cheng et al., "An epi-detected coherent anti-Stokes Raman scattering
(E-CARS) microscope with high spectral resolution and high sensi-
tivity", J. Phys. Chem, 105(7), pp. 1277-1280, 2001.
Hashimoto et al., "Molecular vibration imaging in the fingerprint
region by use of coherent anti-Stokes Raman scattering microscopy
with a collinear configuration", Opt. Lett., 25(24), pp. 1768-1770,
2000.
Volkmer et al., "Vibrational imaging with high sensitivity via
epidected coherent anti-Stokes Raman scattering microscopy", Phys.
Rev. Lett., 87(2):023901-1-4, 2001.
Schmitt, J.M. et al., "Optical-coherence tomography of a dense tis-
sue: statistics of attenuation and backscattering", Phys. Med. Biol.,
vol. 39, pp. 1705-1720, (1994).
Tearney, G.J. et al., "In vivo endoscopic optical biopsy with optical
coherence tomography", Science, vol. 276, pp. 2037-2039, (1997).
Huang, D. et al., "Optical Coherence Tomography", Science, 254,
5035, pp. 1178-1181, (1991).
Fercher, A.F. et al., "Optical Coherence Tomography principles
and applications", Institute of Physics Publishing, Reports on
Progress in Physics, 66, pp. 239-303, (2003).
US 7,725,169 B2
Page 8
Boppart, S.A. et al., "Optical probes and techniques for molecular
contrast enhancement in coherence imaging", J. Biomedical Optics,
10(4), pp. 041208-1 thru 041208-14, (2005).
Oldenburg, A.L. et al., "Imaging magnetically labeled cells with
magnetomotive optical coherence tomography", Optics Letters, 30,
7, pp. 747-749, (2005).
Oldenburg, A.L. et al., "Selective OCT imaging of cells using mag-
netically-modulated optical contrast agents", in Proceedings of the
Conference on Lasers and Electro-Optics, pp. 405-4-6, (2003).
Kopelman, R. et al., "Multifunctional nanoparticle platforms for in
vivo MRI enhancement and photodynamic therapy of a rat brain
cancer", J. Magnetism and Magnetic Materials, 293, pp. 404-410,
(2005).
Romanus, E. et al., "Magnetic nanoparticle relaxation measurement
as a novel tool for in vivo diagnostics", J. Magnetism and Magnetic
Materials, 252, pp. 387-389, (2002).
Oldenburg, A.L. et al., "Magnetomotive contrast for in vivo optical
coherence tomography", Optics Express, 13, 17, pp. 6597-6614,
(2005).
Oh, J. et al., "Detection of magnetic nanoparticles in tissue using
magneto-motive ultrasound", Nanotechnology, 17, pp. 4183-4190,
(2006).
Joo, C. et al., "Spectral-domain optical coherence phase microscopy
for quantitative phase-contrast imaging", Optics Letters, 30, 16, pp.
2131-2133,(2005).
Choma, M.A. et al., "Spectral-domain phase microscopy", Optics
Letters, 30, 10, pp. 1162-1164, (2005).
Choma, M.A. et al., "Doppler flow imaging of cytoplasmic streaming
using spectral domain phase microscopy", J. Biomedical Optics
11(2), pp. 024014-1 thru 024014-8, (2006).
Sticker, M. et al., "En face imaging of single cell layers by differential
phase-contrast optical coherence microscopy", Optics Letters, 27,
13, pp. 1126-1128, (2002).
Sarunic, M.V. et al., "Full-field swept-source phase microscopy",
Optics Letters, 31, 10, pp. 1462-1464, (2006).
De la Torre-Ibarra, M.H. et al., "Double-shot depth-resolved dis-
placement field measurement using phase-contrast spectral optical
coherence tomography", Optics Express, 14, 21, pp. 9643-9656,
(2006).
Vakoc, B.J. et al., "Phase-resolved optical frequency domain imag-
ing", Optics Express, 13, 14, pp. 5483-5493, (2005).
Pedersen, C.J. et al., "Phase-referenced Doppler optical coherence
tomography in scattering media", Optics Letters, 30, 16, pp. 2125-
2127, (2005).
Ren, H. et al., "Imaging and quantifying transverse flow velocity with
the Doppler bandwidth in a phase-resolved functional optical coher-
ence tomography", Optics Letters, 27, 6, pp. 409-411, (2002).
Zhao, Y. et al., "Doppler standard deviation imaging for clinical
monitoring of in vivo human skin blood flow", Optics Letters, 25, 18,
pp. 1358-1360, (2000).
Ren, H. et al., "Phase-resolved functional optical coherence
tomography: simultaneous imaging of in situ tissue structure, blood
flow velocity, standard deviation, birefringence, and Stokes vectors
in human skin", Optics Letters, 27, 19, pp. 1702-1704, (2002).
Ding, Z. et al., "Real-time phase-resolved optical coherence
tomography and optical Doppler tomography", Optics Express, 10,
5, pp. 236-244, (2002).
White, B.R. et al., "In vivo dynamic human retinal blood flow imag-
ing using ultra-high-speed spectral domain optical Doppler
tomography", Optics Express, 11, 25, pp. 3490-3496, (2003).
Ren, H. et al., "Real-time in vivo blood-flow imaging by moving-
scatterer-sensitive spectral-domain optical Doppler tomography",
Optics Letters, 31, 7, pp. 927-929, (2006).
Fang-Yen, C. et al., "Noncontact measurement of nerve displacement
during action potential with a dual-beam low-coherence
interferometer", Optics Letters, 29, 17, pp. 2028-2030, (2004).
Choma, M.A. et al., "Sensitivity advantage of swept source and
Fourier domain optical coherence tomography", Optics Express, vol.
11, No. 18, pp. 2183-2189, (2003).
Leitgeb, R. et al., "Performance of fourier domain vs. time domain
optical coherence tomography", Optics Express, 11, 8, pp. 889-894,
(2003).
Leitgeb, R.A. et al., "Ultrahigh resolution Fourier domain optical
coherence tomography", Optics Express, 12, 10, pp. 2156-2165,
(2004).
De Boer, J.F. et al., "Improved signal-to-noise ratio in spectral-do-
main compared with time-domain optical coherence tomography",
Optics Letters, 28, 21, pp. 2067-2069, (2003).
Ralston, T.S. et al., "Phase Stability Technique for Inverse Scattering
in Optical Coherence Tomography", International Symposium on
Biomedical Imaging, pp. 578-581, (2006).
Yang, C. "Molecular contrast optical coherence tomography: A
review", Photochemistry and Photobiology 81, pp. 215-237, (2005).
Kim, J. et al., "Hemoglobin contrast in magnetomotive optical Dop-
pler tomography", Optics Letters, 31, 6, pp. 778-780, (2006).
Oh, J. etal., "Magneto-motive detection oftissue-basedmacrophages
by differential phase optical coherence tomography", Lasers in Sur-
gery and Medicine, 39, pp. 266-272, (2007).
Crecea, V. et al., "Phase-resolved spectral-domain magnetomotive
optical coherence tomography", Proc. of SPIE, 6429, pp. 64291X-1
thru 64291X-10, (2007).
Oldenburg, A.L. et al., "Magnetic contrast agents for optical coher-
ence tomography", Proc. of SPIE, 5316, pp. 91-92, (2004).
Oldenburg, A.L. et al., "High-resolution in vivo nanoparticle imaigng
using magnetomotive optical coherence tomography", Proc. of SPIE,
6097, pp. 609702-1 thru 609702-11, (2006).
Schmitt, J.M. "OCT elastography: imaging microscopic deformation
and strain of tissue", Optics Express, 3, 6, pp. 199-211, (1998).
Gleich, B. et al., "Tomographic imaging using the nonlinear response
of magnetic particles", Nature, 435, pp. 1214-1217, (2005).
Anker, J.N. et al., "Magnetically modulated optical nanoprobes",
Applied Physics Letters, 82, 7, pp. 1102-1104, (2003).
Harisinghani, M.G. et al., "Noninvasive Detection of Clinically
Occult Lymph-Node Metastases in Prostate Cancer", New England J.
of Medicine, 348, 25, pp. 2491-2499, (2003).
Arbab, A.S. et al., "In vivo trafficking and targeted delivery of mag-
netically labeled stem cells", Human Gene Therapy, 15, pp. 351-360,
(2004).
Alexiou, C. et al., "Locoregional cancer treatment with magnetic
drug targeting", Cancer Research, 60, pp. 6641-6648, (2000).
Winter, P.M. et al., "Molecular imaging of angiogenesis in early-
stage atherosclerosis with integrin-targeted nanoparticles", Circula-
tion, 108, pp. 2270-2274, (2003).
Mornet S. et al., "Magnetic nanoparticle design for medical diagnosis
and therapy", J. of Materials Chemistry, 14, pp. 2161-2175, (2004).
Kim, J. et al., "Imaging nanoparticle flow using magneto-motive
optical Doppler tomography", Nanotechnology, 18, 035504, pp. 1-6,
(2007).
Oldenburg, A.L. et al., "Spectral-Domain Magnetomotive OCT
Imaging of Magnetic Nanoparticle Biodistribution", Proc. of SPIE,
vol. 6847, pp. 684719-1 thru 684719-8, (2008).
Oldenburg, A.L. et al., "Phase-resolved magnetomotive OCT for
imaging nanomolar concentrations of magnetic nanoparticles in tis-
sues", Optics Express, 16(15), pp. 11525-11539, (2008).
Oldenburg, A.L. et al., "Optical micro-scale mapping of dynamic
biomechanical tissue properties", Optics Express, 16(15), pp. 11052-
11065, (2008).
Oldenburg, A.L. et al., "Spectroscopic optical coherence tomography
and microscopy", IEEE Journal of Selected Topics in Quantum Elec-
tronics, special issue on Biophotonics, 13(6), pp. 1629-1640, (2007).
Zysk, A.M. et al., "Optical coherence tomography: A review of
clinical development from bench to bedside", Special section on
optical diagnostic imaging from bench to bedside, Journal of Bio-
medical Optics, 12(5), pp. 051403-1 thru 051403-20,  (2007).
Tan, W. et al., "Optical coherence tomography of cell dynamics in
three-dimensional tissue models", Optics Express, 14(16), pp. 7159-
7171, (2006).
Oldenburg, A.L. et al., "Plasmon-resonant gold nanorods as law
backscattering albedo contrast agents for optical coherence
tomography", Optics Express, vol. 14, No. 15, pp. 6724-6738,
(2006).
Senin, A.A. et al., "Molecular dissociation observed with an atomic
wavepacket and parametric four-wave mixing", Chemical Physics
Letters, 381, pp. 53-59, (2003).
US 7,725,169 B2
Page 9
Oldenburg, A.L. et al., "Fast Fourier-domain delay line for in vivo
optical coherence tomography with a polygonal scanner", Applied
Optics, 42(22), pp. 4606-4611, (2003).
Marks, D.L. et al., "Autofocus algorithm for dispersion correction in
optical coherence tomography", Applied Optics, 42(16), pp. 3038-
3046, (2003).
Marks, D.L. et al., "Digital algorithm for dispersion correction in
optical coherence tomography for homogeneous and stratified
media", Applied Optics, vol. 42, No. 2, pp. 204-217, (2003).
Oldenburg, A.L. et al., "Vibrational wave packets in theBinµand
D":,' states of Cs2: Determination of improved Cs2+(X) and Cs2(B)
spectroscopic constants", Journal of Chemical Physics, 113(24), pp.
11009-11018, (2000).
Oldenburg, A.L. et al., "Optically pinpointing magnetic
nanoparticles within biological tissue", Optics & Photonics News,
17(12), p. 24, (2006).
Nguyen, F.T. et al., "Magnetic protein microspheres as dynamic
contrast agents for magnetomotive optical coherence tomography",
Proc. of SPIE, 6867, pp. 68670F-1 thru 68670F-11, (2008).
Oldenburg, A.L. et al., "Plasmon-resonant gold nanorods provide
spectroscopic OCT contrast in excised human breast tumors", Proc.
of SPIE, 6867, pp. 68670E-1 thru 68670E-10, (2008).
Oldenburg, A.L. et al., "Spectral-domain magnetomotive OCT imag-
ing of magnetic nanoparticle biodistribution", Proc. of SPIE, 6847,
pp. 684719-1 thru 684719-11, (2008).
Liang, X. et al., "Modeling and measurement of tissue elastic moduli
using optical coherence elastography", Proc. of SPIE, 6858, pp.
685803-1 thru 685803-8,(2008).
Oldenburg, A.L. et al., `Backscattering albedo contrast in OCT using
plasmon-resonant gold nanorods", Proc. of SPIE, 6429, pp.
64291Z-1 thru 6429Z-8, (2007).
Oldenburg, A.L. et al., "Characterization of plasmon-resonant gold
nanorods as near-infrared optical contrast agents investigated using a
double-integrating sphere system", Proc. of SPIE, 5703, pp. 50-60,
(2005).
Oldenburg, A.L. et al., "Magnetic contrast agents for optical coher-
ence tomography." Proc. of SPIE, 5316, pp. 91-98, (2004).
Oldenburg, A.L. et al., "Optical manipulation of silicon
microparticles in biological environments", Proc. of SPIE, 4962, pp.
249-255,(2003).
Oldenburg, A.L., "Wavepacket dynamics and time-domain spectros-
copy in atomic rubidium", Quantum Electronics and Laser Science
Conference 1999, Technical Digest, Thursday Morning, pp. 176-177,
(1999).
Swanson, E.A. et al., "In vivo retinal imaging by optical coherence
tomography", Optics Letters, 18, 21, pp. 1864-1866, (1993).
American Academy of Pediatrics, Clinical Practice Guideline,
"Otitis Media with Effusion", Pediatrics, 113, 5, pp. 1412-1429,
(2004).
Pitris, C. et al., "High-resolution imaging of the middle ear with
optical coherence tomography: A feasibility study," Arch
Otolaryngol Head Neck Surg., 127, pp. 637-642, (2001).
Hall-Stoodley, L. et al., "Direct detection of bacterial biofilms on the
middle-ear mucosa of children with chronic otitis media," JAMA,
296, 2, pp. 202-211, (2006).
Xi, C. et al., "High-resolution three-dimensional imaging of biofilm
development using optical coherence tomography," J. Biomed. Opt.,
11(3), pp. 034001-1 thru 034001-6, (2006).
Leitgeb, R. et al., "Performance of Fourier domain vs. time domain
optical coherence tomography," Optics Express, 11, 8, 889-894,
(2003).
Ralston, T.S. et al., "Interferometric synthetic aperture microscopy",
Nature Physics, 3, pp. 129-134, (2007).
Ralston, T.S. et al., "Inverse Scattering for Optical Coherence
Tomography", J. Opt. Soc. Am. A, 23, 5, pp. 1027-1037, (2006).
Sitter, D.N. et al., "Three-dimensional Imaging: a Space invariant
Model for Space Variant Systems", Applied Optics, 29, 26, pp. 3789-
3794,(1990).
Choma, M.A. et al., "Sensitivity advantage of swept source and
Fourier domain optical coherence tomography", Optics Express, 11,
18, pp. 2183-2189, (2003).
Ralston, T.S. et al., "Phase Stability Technique for Inverse Scattering
in Optical Coherence Tomography", Biomedical Imaging: Nano to
Macro, 3rd IEEE International Symposium on Biomedical Imaging,
pp. 578-581, (2006).
Costerton, J.W. et al., `Bacterial biofilms: a common cause of per-
sistent infections", Science, 284, pp. 1318-1322, (1999).
Donlan, R.M., `Biofilms and device-associated infections", Emerg-
ing Infectious Diseases, 7, 2, pp. 277-281, (2001).
Donlan, R.M. `Biofilms: microbial life on surfaces", Emerging
Infectious Diseases, 8, 9, pp. 881-890, (2002).
Fux, C.A. et al., "Survival strategies of infectious biofilms", Trends in
Microbiology, 13, 1, pp. 34-40, (2005).
Takata, G.S. et al., "Evidence Assessment of the Accuracy of Meth-
ods of Diagnosing Middle Ear Effusion in Children With Otitis
Media With Effusion", Pediatrics, 112, 6, pp. 1379-1387, (2003).
Reed, W.A. et al., "Gradient-index fiber-optic microprobes for mini-
mally invasive in vivo low-coherence interferometry," Optics Letters,
27, 20, pp. 1794-1796, (2002).
Vinegoni, C. et al., "Integrated structural andfunctional optical imag-
ing combining spectral-domain optical coherence and multiphoton
microscopy", Applied Physics Letters, 88, pp. 053901-1 thru
053901-3, (2006).
Crecea, V., "Phase-resolved spectral-domain magnetomotive optical
coherence tomography for microscopic analysis of biomechanical
properties", Preliminary Examination, pp. 1-15, (2007).
Xu, C. et al., "Near-infrared dyes as contrast-enhancing agents for
spectroscopic optical coherence tomography", Optics Letters, vol.
29, No. 14, pp. 1657-1649, (2004).
Nguyen, F.T. et al., "Portable Real-Time Optical Coherence
Tomography System for Intraoperative Imaging and Staging of
Breast Cancer", Proc. Of SPIE, vol. 6430, pp. 64300H-1 thru
64300H1-10, (2007).
Zysk, A.M. et al., "Needle-probe system for the measurement of
tissue refractive index", Proc. Of SPIE, vol. 6430, pp. 643000-1-
643000-8, (2007).
Pasquesi, J.J. et al., "Detection of ultrastructural changes in geneti-
cally-altered and exercised skeletal muscle using PS-OCT", Proc. Of
SPIE, vol. 6079, pp. 607926-1-607926-7, (2006).
Xu, C. et al., "Spectroscopic spectral-domain optical coherence
microscopy", Optics Letters, vol. 31, No. 8, pp. 1079-1081, (2006).
Jones, G.W. et al., "High-spectral-resolution coherent anti-stokes
raman scattering with interferometrically detected broadband
chirped pulses", Optics Letters, vol. 31, No. 10, pp. 1543-1545,
(2006).
Boppart, S.A., "Advances in contrast enhancement for optical coher-
ence tomography", Proceedings of the 28th IEEE EMBS Annual
International Conference New York City, USA, pp. 121-124, Aug.
30-Sep. 3, 2006.
Marks, D.L. et al., "High numerical aperture full-field optical coher-
ence tomography with space-invariant resolution without scanning
the focus", Proc. Of SPIE, vol. 6429, pp. 64291R1-64291R-9,
(2007).
Luo, W. et al., "Three-dimensional optical coherence tomography of
the embryonic murine cardiovascular system", Journal of Biomedi-
cal Optics, vol. 11(2), pp. 021014-1-021014-8, (2006).
Marks, D.L. et al., "Inverse scattering for frequency-scanned full-
field optical coherence tomography", Journal of the Optical Society
of America A, vol. 24, No. 4, pp. 1034-1041, (2007).
Ralston, T.S. et al., "Inverse scattering for high-resolution
interferometric microscopy", Optics Letters, vol. 31, No. 24, pp.
3585-3587, (2006).
Ralston, T.S. et al., "Demonstration of inverse scattering in optical
coherence tomography", Proc. Of SPIE, vol. 6079, pp. 60791T-1-
60791T-9, (2006).
Marks, D.L. et al., "Inverse scattering for rotationally scanned optical
coherence tomography", J. Opt. Soc. Am. A, vol. 23, No. 10, pp.
2433-2439,(2006).
Zysk, A.M. et al., "Needle-based reflection refractometry of scatter-
ing samples using coherence-gated detection", Optics Express, vol.
15, No. 8, pp. 4787-4794, (2007).
Pasquesi, J.J. et al., "In vivo detection of exercise-induced
ultrastructural changes in genetically-altered murine skeletal muscle
US 7,725,169 B2
Page 10
using polarization-sensitive optical coherence tomography", Optics
Express, vol. 14, No. 4, pp. 1547-1556, (2006).
Ko, H.J. et al., "Optical coherence elastography of engineered and
developing tissue", Tissue Engineering, vol. 12, No. 1, pp. 63-73,
(2006).
Zhu, C. et al., "Use of a multiseparation fiber optic probe for the
optical diagnosis of breast cancer", Journal of Biomedical Optics,
vol. 10(2), p. 024032-1-024032-13, (2005).
Bigio, I.J. et al., "Diagnosis of breast cancer using elastic-scattering
spectroscopy: preliminary clinical results", Journal of Biomedical
Optics, vol. 5, No. 2, pp. 221-228, (2000).
Bitar, R.A. et al., `Biochemical analysis of human breast tissues
using Fourier-transform Raman spectroscopy", Journal of Biomedi-
cal Optics, vol. 11(5), p. 054001-1-054001-8, (2006).
Demos, S.G. et al., "Investigation of near-infrared autofluorescence
imaging for the detection of breast cancer", IEEE Journal of Selected
Topics in Quantum Electronics, vol. 11, No. 4, pp. 791-798, (2005).
Demos, S.G. et al., "Advances in optical spectroscopy and imaging of
breast lesions", Journal of Mammary Gland Biology and Neoplasia,
vol. 11, pp. 165-181, (2006).
Fournier, L.S. et al., "In-vivo NIR autofluorescence imaging of rat
mammary tumors", Optics Express, vol. 14, No. 15, pp. 6713-6723,
(2006).
Frank, C.J. et al., "Characterization of human breast biopsy speci-
mens with near-IR Raman-spectroscopy", Analytical Chemistry, vol.
66, No. 3, pp. 319-326, (1994).
Gupta, P.K. et al., "Breast cancer diagnosis using N2 laser excited
autofluorescence spectroscopy", Lasers in Surgery and Medicine,
vol. 21, pp. 417-422, (1997).
Haka, A.S. et al., "Identifying microcalcifications in benign and
malignant breast lesions by probing differences in their chemical
composition using Raman spectroscopy", Cancer Research, vol. 62,
pp. 5375-5380, (2002).
Haka, A.S. et al., "Diagnosing breast cancer by using Raman spec-
troscopy", Proceedings of the National Academy of Sciences of the
United States ofAmerica, vol. 102, No. 35, pp. 12371-12376,(2005).
Haka, A.S. et al., "In vivo margin assessment during partial
mastectomy breast surgery using Raman spectroscopy", Cancer
Research, vol. 66, pp. 3317-3322, (2006).
Iftimia, N.V. et al., "A portable, low coherence interferometry based
instrument for fine needle aspiration biopsy guidance", Review of
Scientific Instruments, vol. 76, p. 064301-1-064301-6, (2005).
Lenkinski, R.E. et al., "Near-infrared fluorescence imaging of
microcalcification in an animal model of breast cancer", Academic
Radiology, vol. 10, pp. 1159-1164, (2003).
Manoharan, R. et al., "Raman spectroscopy and fluorescence photon
migration for breast cancer diagnosis and imaging", Photochemistry
and Photobiology, vol. 67(1), pp. 15-22, (1998).
Motz, J.T. et al., "Optical fiber probe for biomedical Raman spec-
troscopy", Applied Optics, vol. 43, No. 3, pp. 542-554, (2004).
Palmer, G.M. et al., "Diagnosis of breast cancer using optical spec-
troscopy", Medical Laser Application, vol. 18, pp. 233-248, (2003).
Palmer, G.M. et al., "Comparison ofmultiexcitation fluorescence and
diffuse reflectance spectroscopy for the diagnosis of breast cancer",
IEEE Transactions on Biomedical Engineering, vol. 50, No. 11, pp.
1233-1242,(2003).
Peters, V.G. et al., "Optical properties of normal and diseased human
breast tissues in the visible and near infrared", Physics in Medicine
and Biology, vol. 35, No. 9, pp. 1317-1334, (1990).
Redd, D.C.B. et al., "Raman spectroscopic characterization ofhuman
breast tissues: Implications for breast cancer diagnosis", Applied
Spectroscopy, vol. 47, No. 6, pp. 787-791, (1993).
Shafer-Peltier, A.S. et al., "Raman micro spectroscopic model of
human breast tissue: implications for breast cancer diagnosis in
vivo', Journal of Raman Spectroscopy, vol. 33, pp. 552-563, (2002).
Shah, N. et al., "Noninvasive functional optical spectroscopy of
human breast tissue", Proceedings of the National Academy of Sci-
ences ofthe United States ofAmerica, vol. 98, No. 8, pp. 4420-4425,
(2001).
Shetty, G. et al., "Raman spectroscopy: elucidation of biochemical
changes in carcinogenesis ofoesophagus", British Journal of Cancer,
vol. 94, pp. 1460-1464, (2006).
Yang, Y. et al., "Fundamental differences of excitation spectrum
between malignant and benign breast tissues", Photochemistry and
Photobiology, vol. 66(4), pp. 518-522, (1997).
Zysk, A.M. et al., "Optical coherence tomography: a review of clini-
cal development from bench to bedside", J. Biomedical Optics,
12(5), pp. 051403-1 thru 051403-21, (2007).
Choi, J.H. et al., "Multimodal biomedical imaging with asymmetric
single-walled carbon nanotube/iron oxide nanoparticle complexes",
Nano Letters, vol. 7, No. 4, pp. 861-867, (2007).
Zysk, A.M. et al., Comment on "In vivo cancer diagnosis with optical
spectroscopy and acoustically induced blood stasis using a murine
Mca35 model", Medical Physics, vol. 34, Issue 3, p. 1130, (2007).
Boppart, M.D. et al., "a7 (31 Imegrin regulates mechanotransduc-
tion andprevents skeletal muscle injury", American Journal ofPhysi-
ology: Cell Physiology, vol. 290, Issue 6, pp. C1660-C1665, (2006).
Toublan, F.J-J. et al., "Tumor targeting by surface-modified protein
microspheres", Journal of the American Chemical Society, vol. 128,
Issue 11, pp. 3472-3473, (2006).
Vinegoni, C. et al., "Integrated structural andfunctional optical imag-
ing combining spectral-domain optical coherence and multiphoton
microscopy", Applied Physics Letters, vol. 88, Issue 5, pp. 053901-1
thru 053901-3, (2006).
Vinegoni, C. et al., "Multi-modality imaging of structure and func-
tion combining spectral-domain optical coherence and multiphoton
microscopy", Proc. of SPIE, vol. 6079, pp. 60791D-1 thru 60791D-8,
(2006).
Boppart, S.A. et al., "Real-time optical biopsy and analysis of breast
cancer using clinical optical coherence tomography", Journal of
Clinical Oncology, Abstract presentation from the 2007 ASCO
Annual Meeting Proceedings Part 1, vol. 25, No. 18S, (2007).
American Cancer Society, "2007 Cancer facts & figures", 56 pages,
(2007).
Boppart, S.A. et al., "Optical coherence tomography: feasibility for
basic research and image-guided surgery of breast cancer", Breast
Cancer Research and Treatment, vol. 84, pp. 85-97, (2004).
Berg, W.A. et al., "Diagnostic accuracy of mammography, clinical
examination, US, and MR imaging in preoperative assessment of
breast cancer", Radiology, vol. 233, pp. 830-849, (2004).
Kawasaki, M., et al., "Diagnostic accuracy of optical coherence
tomography and integrated backscatter intravascular ultrasound
images for tissue characterization ofhuman coronary plaques", Jour-
nal of the American College of Cardiology, vol. 48, No. 1, pp. 81-88,
(2006).
Oldenburg, A.L. et al., "Molecular OCT contrast enhancement and
imaging", Optical Coherence Tomography: Technology and Appli-
cations, Ch. 24, (2008).
Oldenburg, A.L. et al., "Optical coherence tomography", McGraw-
Hill Encyclopedia of Science & Technology, (2005).
Oldenburg, AL et al., "Imaging gold nanorods in excised human
breast carcinoma by spectroscopic optical coherence tomography",
Journal of Materials Chemistry, (2009).
* cited by examiner
U.S. Patent	 May 25, 2010	 Sheet 1 of 12	 US 7,725,169 B2
100
110
Selecting at least one contrast agent
Delivering the at least one
	
120
contrast agent to tissue
Acquiring SOCT data from the 	 130
tissue
Converting the SOCT data	 140
into at least one image
FIG. 1
U.S. Patent	 May 25, 2010	 Sheet 2 of 12	 US 7,725,169 B2
210
Determining the optical window
of the tissue
200 ^^
Selecting a laser spectrum range 	 220
within the optical window
Selecting at least one contrast agent 	 230
that optically modifies radiation within
the laser spectrum range
----------------------------------------------------
Selecting at least one contrast agent that 	 240
can be delivered to the tissue
FOG. 2
U.S. Patent	 May 25, 2010	 Sheet 3 of 12	 US 7,725,169 B2
FIG.
U.S. Patent	 May 25, 2010	 Sheet 4 of 12	 US 7,725,169 B2
Performing time-frequency analysis
	 410





analysis on the data
Retrieving the spatial distribution of the at least
	 430
one contrast agent in the tissue
Correlating the spatial distribution with
	
440
at least one display parameter
FIG. 4








U.S. Patent	 May 25, 2010	 Sheet 5 of 12	 US 7,725,169 B2



























































10,	 102	 103	 109
dye concentration (ug/ml)
FIG. 8
U.S. Patent	 May 25, 2010	 Sheet 9 of 12	 US 7,725,169 B2
FIG.









%0 750	 800	 850	 900
wavelength ^nm
FIG.
U.S. Patent	 May 25, 2010	 Sheet 11 of 12	 US 7,725,169 B2
FIG.  i






CONTRAST ENHANCED SPECTROSCOPIC 	 SUMMARY
OPTICAL COHERENCE TOMOGRAPHY
REFERENCE TO RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional
Application No. 60/672,205 entitled "Contrast Enhanced
Spectroscopic Optical Coherence Tomography" filedApr. 15,
2005, which is incorporated by reference in its entirety.
FEDERALLY SPONSORED RESEARCH OR
DEVELOPMENT
The subject matter of this application may have been
funded in part under a research grants from the National
Aeronautics and Space Administration (NASA), under Con-
tract Number NAS2-02057. The U.S. Government may have
rights in this invention.
BACKGROUND
Optical coherence tomography (OCT) is a high-resolution
medical and biological imaging technology. OCT has been
used in ophthalmology for high-resolution tomographic
imaging of the retina and anterior eye. Recently, the technique
has been applied for imaging a wide range of nontransparent
tissues to investigate applications in tissues studies and medi-
cal applications in gastroenterology, urology, and neurosur-
gery. OCT detects the reflections of low-coherence light, and
cross-sectional imaging may be performed by measuring the
backscattered intensity of light from structures in tissue. This
imaging technique is attractive for medical imaging because
it permits the imaging of tissue microstructure in situ. In situ
imaging with OCT may provide micron-scale imaging reso-
lution without the need for excision and histological process-
ing.
Spectroscopic optical coherence tomography (SOCT) is an
extension of OCT that can provide depth resolution and can
differentiate between different types of tissue. In addition to
the normal OCT measurement of the intensity of light back-
scattered from the sample, SOCT measures the spectral
absorption and reflectance data from the tissue. Tissue struc-
ture can be resolved based on local optical densities, ignoring
the frequency dependent changes. SOCT resolves both the
amplitude, which contains the density information, and the
frequency, which contains the spectroscopic molecular com-
position information.
Contrast agents may be used to improve the resolution of
images obtained from an imaging technique, including OCT.
Conventional contrast agents serve to increase the intensity of
backscattered light. For example, air-filled micro-bubbles
and engineering microspheres may be introduced into tissue
to increase the back-scattering from tissue. In another
example, a molecular contrast agent can be generated using a
pump-probe technique to change the absorption.
A method to increase the types of tissue that may be
resolved with SOCT methods would be beneficial. For
example, substances such as melanin and hemoglobin exhibit
strong selective absorption signature, and may be directly
resolved by conventional SOCT. However, these substances
are common in tissue and often may not be used to discrimi-
nate tissue types. It would be desirable to provide contrast
agents that could improve and expand the application of
SOCT. It would also be desirable to extract additional infor-
mation from tissue samples regarding the structure and the
composition of the tissue.
In one aspect, the invention provides a method of forming
an image of a sample.
5	 In another aspect, the invention provides a method of per-
forming SOCT on a sample.
In yet another aspect, the invention provides a method of
selecting a contrast agent.
In yet another aspect, the invention provides a method of
io selecting a combination of an absorbing agent and a scatter-
ing agent.
In yet another aspect, the invention provides a method of
performing SOCT on a sample comprising at least one
absorbing agent and at least one scattering agent.
15	 In yet another aspect, the invention provides a method of
enhancing the contrast of an image of a sample.
In yet another aspect, the invention provides a method of
separately quantifying the contributions to SOCT data of at
least one absorbing agent and at least one scattering agent in
20 a sample.
In yet another aspect, the invention provides a method of
forming an image of tissue that includes selecting at least one
contrast agent, delivering the at least one contrast agent to the
tissue, acquiring SOCT data from the tissue, and converting
25 the SOCT data into at least one image.
In yet another aspect, the invention provides a method of
forming an image of tissue that includes selecting at least one
contrast agent, delivering the at least one contrast agent to
tissue, acquiring SOCT data from the tissue, and converting
30 the SOCT data into at least one image. The at least one
contrast agent includes at least one water-soluble, biocom-
patible absorbing agent.
In yet another aspect, the invention provides a method of
forming an image of tissue that includes determining the
35 optical window of living tissue, selecting a laser spectrum
range that is within the optical window, selecting at least one
water-soluble, biocompatible absorbing agent that absorbs
within the laser spectrum range, selecting at least one scat-
tering agent that scatters within the laser spectrum range,
4o delivering the at least one absorbing agent and the at least one
scattering agent to the living tissue, acquiring SOCT data
from the living tissue, performing time-frequency analysis on
the data, performing spectral/pattern analysis on the data,
retrieving the spatial distributions of the at least one absorb-
45 ing agent and of the at least one scattering agent in the living
tissue, and correlating the spatial distributions with at least
one display parameter.
In yet another aspect, the invention provides a method of
converting SOCT data into at least one image that includes
50 performing time-frequency analysis on SOCT data from tis-
sue, performing spectral/pattern analysis on the SOCT data,
retrieving the spatial distribution of at least one contrast agent
in the tissue, and correlating the spatial distribution with at
least one display parameter.
55 The scope of the present invention is defined solely by the
appended claims and is not affected by the statements within
this summary.
BRIEF DESCRIPTION OF THE DRAWINGS
60
The invention can be better understood with reference to
the following drawings and description. The components in
the figures are not necessarily to scale, emphasis instead
being placed upon illustrating the principles of the invention.
65	 FIG. 1 depicts a method of forming an image of tissue.






FIG. 3 is a schematic representation of a device for acquir- 	 be selected, the method 200 optionally may include selecting
ing SOCT data.	 at least one contrast agent that can be delivered to the tissue
FIG. 4 depicts a method of converting SOCT data into at 	 240.
least one image.	 Determining the tissue optical window 210 may include
FIG. 5 is a graph of scattering loss for a series ofmicrobead 5 determining a wavelength region of electromagnetic radia-
solutions and tissue samples, together with a graph of absorp- 	 tion that is only minimally absorbed by the tissue. When
tion attenuation for an absorbing agent solution. 	 radiation having a wavelength within this optical window is
FIG. 6 is a schematic representation of a phantom sample	 passed through the tissue, attenuation of the radiation is gov-
and of a display of an SOCT image of the sample.	 erned by scattering rather than absorbance. Ultraviolet radia-
FIG. 7 is a graph of the emission spectrum of a laser, io tion and infrared radiation are absorbed by the majority of
together with the absorption spectrum of an absorbing agent. 	 substances in biological systems, such as water, proteins
FIG. 8 is a graph of the centroid of a backreflected light	 without chromophores, carbohydrates, nucleic acids and lip-
spectrum as a function of absorbing agent concentration. 	 ids. Accordingly, the tissue optical window for most tissues is
FIG. 9 is a series of images of the tissue of a celery stalk. 	 in the near-infrared (NIR) region, typically from 600 mu to
FIG. 10 is a graph of absorption spectra obtained using a 15 1500 mu. Analysis within the tissue optical window is pre-
variety of time-frequency distributions. 	 ferred for deep tissue imaging.
FIG. 11 is a series of images of rat mammary tissues. 	 Selecting a laser spectrum range that falls within the tissue
FIG. 12 is a series of single-cell images of a GFP-vinculin 	 optical window 220 may include selecting a laser source that
transfected fibroblast. 	 emits radiation over a wavelength range within the optical
20 window. Preferably the center wavelength of the radiation is
DETAILED DESCRIPTION	 within the optical window. The radiation emitted by a laser
may also be filtered or frequency shifted so as to produce
The present invention makes use of the discovery that 	 radiation within the tissue optical window.
contrast agents can be selected and delivered to tissue to 	 Selecting at least one contrast agent 230 may include
provide for enhancement of the contrast in SOCT imaging. 25 selecting at least one substance that changes one or more
By the site-specific and molecule-specific introduction of 	 optical properties of tissue containing the substance when
absorbing agents and/or scattering agents, the invention	 subjected to radiation within the laser spectrum range. There
improves OCT imaging quality, widens OCT usage areas, and	 must be overlap between the laser spectrum range and the
provides a means of molecular imaging. The present inven-	 spectrum range in which the substance optically modifies
tion also includes the use of both absorbing agents and scat-
 so radiation. Selecting at least one contrast agent 230 may also
tering agents in the same tissue to enhance SOCT image 	 include selecting at least two substances, each of which opti-
contrast. In addition, it has been discovered that the contribu- 	 cally modifies radiation passing through the tissue. Prefer-
tions of an absorbing agent and a scattering agent to the 	 ably each substance modifies a different property of the radia-
optical properties of contrast-enhanced tissue can be quanti- 	 tion and/or modifies radiation within a different portion of the
fied separately. SOCT imaging that incorporates and analyzes 35 laser spectrum range.
contrast agents according to the present invention can provide	 Selecting at least one contrast agent that can be delivered to
for improvements in the image quality and in the variety of	 the tissue 240 may include determining the relative biocom-
tissues that can be analyzed. 	 patibility of each of the contrast agents that optically modify
The term "contrast agent' means any substance that 	 radiation within the laser spectrum range. Selecting at least
changes the optical properties of tissue containing the sub- 40 one contrast agent that can be delivered to the tissue 240 may
stance. Optical properties that may be changed include absor- 	 also include determining which of the contrast agents that
bance, reflectance, fluorescence, birefringence and optical	 optically modify radiation within the laser spectrum range
scattering.	 can be combined with a delivery vehicle. This selection may
The term "optical modification" means a change in one or 	 include considerations such as stability of the contrast agent,
more optical properties of radiation. 	 45 since the agent should exhibit useful optical modification
The phrase "contrast enhancement' means that an image 	 characteristics when present in the tissue for a period of time
produced with the enhancement shows a greater difference in	 sufficient to perform the analysis. This selection also may
optical properties between parts of the image, than an other- 	 include considerations such as tissue specificity. Certain con-
wise identical image produced without the enhancement.	 trast agents may be preferentially attracted to or absorbed by
The term "image" means data produced by receipt of elec- 5o different types of tissue, making these agents useful for iden-
tromagnetic radiation, which may or may not be formed into 	 tifying these specific tissues. Certain contrast agents may be
a picture viewable by the human eye. This includes images 	 modified to make the agents specific to certain types of tissue
produced directly onto a medium such as film or video.	 orto increase specificity. For example, a non-specific contrast
FIG. 1 represents a method 100 of forming an image of 	 agent may be modified with an antibody that binds to a certain
tissue that includes selecting at least one contrast agent 110, 55 type of tissue, allowing for targeting of that tissue with the
delivering the at least one contrast agent to tissue 120, acquir- 	 contrast agent.
ing SOCT data from the tissue 130, and converting the SOCT 	 The contrast agent may include at least one absorbing
data into at least one image 140. The selecting at least one 	 agent. Radiation that is backscattered from tissue containing
contrast agent 110 may include selecting at least one absorb- 	 an absorbing agent will have a spectrum different from that of
ing agent and/or may include selecting at least one scattering 60 the impinging radiation, since a portion of the spectrum has
agent.	 been absorbed by the absorbing agent in the tissue. Preferably
FIG. 2 represents a method 200 of selecting at least one	 an absorbing agent has an absorption profile that is sharp,
contrast agent that includes determining the optical window 	 meaning that the transition region from a wavelength region
of the tissue 210, selecting a laser spectrum range that is 	 that is highly absorbed to a wavelength region that is subject
within the optical window 220, and selecting at least one 65 to little or no absorption is narrow. A sharper absorption
contrast agent that optically modifies radiation within the 	 profile typically provides for increased analytical sensitivity.
laser spectrum range 230. If more than one contrast agent can 	 Sharp absorption profiles may also be useful if multiple
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absorbing agents are present, as this may provide for simul- 	 filed Jun. 17, 2003, and published as US 2004/0258762 Al.
taneous analysis at different wavelengths. 	 These microspheres may incorporate in their shells and/or in
Examples of absorbing agents include synthetic dyes and 	 their cores a wide range of substances that can alter the local
bio-engineered dyes. Both synthetic and bio-engineered dyes 	 optical properties of tissue. The protein shell may also be
can have absorbance profiles in the near-infrared. Synthetic 5 functionalized to target agents to specific regions of interest.
dyes typically are specific for small molecules and can be 	 The contrast agent may include at least one scattering agent
sensitive to pH or to concentrations of substances such as 	 in addition to the at least one absorbing agent. Examples of
glucose, CO 2 and 02 . These dyes can be useful for detection 	 scattering agents include protein microspheres, microbeads
of tumors, since hypoxia and acidity are two well-known 	 and nanoparticles.
characteristics of tumors that grow above a certain size. Spe- 10	 Protein microspheres have an exterior protein shell and an
cific examples of synthetic dyes include Indocyanine Green, 	 interior containing a gas, a liquid or particles. The composi-
fluorescein, SNARE and Fura Red. Indocyanine Green 	 tions of the shell and the interior may be varied to produce
(Sigma-Aldrich) typically is used for retina angiography,	 microspheres having different spectral scattering properties.
fluorescein (Molecular Probes) typically is used for liver	 The spectral scattering properties may also be affected by the
function testing, SNARE (Molecular Probes) typically is used 15 relative dimensions of the shell and the interior. See, for
as a pH indicator, and Fura Red (Molecular Probes) typically 	 example, U.S. Patent Application Publication Nos. US 2004/
is used as a Ca 21 indicator.	 0258759 Al and US 2004/0258762 Al. The protein in the
Bio-engineered dyes typically are specific for proteins or	 exterior shell can also be engineered such that melanin, gold
for specific cellular structures. Biological basic dyes are	 or carbon particles are embedded. See, for example, Lee, T.
known to preferentially stain nuclei, allowing for determina- 20 M. et al., Optics Letters, 2003, 28(17), 1546-1548.
tion of the nuclear-to-cytoplasm ratio, which is also an impor- 	 Simple microbeads having sizes close to the selected laser
tant indicator of tumor progression. Other examples of bio- 	 wavelength can provide Mie scattering of the laser radiation.
engineered dyes include DNA binding dyes, dye-tagged 	 This spectral scattering can be modified by coating the beads
immunoproteins and natural protein chromophores. Specific 	 with dye or other materials.
examples of bio-engineered dyes include Rhodamine tagged 25	 Metal nanoparticle scattering agents may be solid particles
oligonucleotide and NN382 conjugated anti-human IgG. 	 or may be nanoshells. One advantage of metal nanoparticles
Rhodamine tagged oligonucleotide (EMP Biotech GmbH)	 over other scattering agents is the resistance of the nanopar-
typically is used for DNA sequencing and blotting, and	 ticles to optical, chemical and/or thermal degradation, includ-
NN382 conjugated anti-human IgG (LI-COR Inc.) typically 	 ing denaturation andbleaching. In addition, biomolecules can
is used for protein labeling. 	 3o be bound to nanoparticles using similar techniques to those
Examples of absorbing agents also include particles such	 used for gold colloids. Solid metal nanoparticles may be
as quantum dots, nanospheres, nanorods and nanoshells. Spe- 	 formed in a variety of shapes, which can affect the optical
cific examples of absorbing particles include metal-based 	 scattering properties. Metal nanoshells may have a core con-
nanoparticles, including nanoparticles containing gold, sil- 	 taining a dielectric material, and modifications in the shape,
ver, copper, cobalt, nickel, iron, and alloys or mixtures 35 composition and relative dimensions of core and the shell can
thereof. Specific examples of absorbing particles also include 	 provide for systematic variation of the optical resonance over
plasmon-resonant nanoparticles, such as those described in 	 a broad wavelength region, ranging from near-UV to the
copending U.S. patent application Ser. No. 10/753,972 to 	 mid-infrared. Gold nanoshells may be engineered to scatter or
Boppart et al., filed Jan. 8, 2004, and published as US 2005/	 absorb light primarily in the wavelength ranges typically used
0171433 Al. Plasmon-resonant nanoparticles include metal- 40 for OCT.
lic nanopaticles that have an extinction coefficient of at least 	 Crystalline nanoparticles containing dielectric material
106 M-1 cm- ' at some frequency in the infrared to ultraviolet 	 may also be scattering agents. Examples of crystalline nano-
spectrum (electromagnetic radiation in the frequency range 	 particles include Bragg reflectors and photonic crystals. Light
of 10 12 to 1017 Hz).	 traveling through these nanoparticles undergoes a periodic
Examples of absorbing agents also include genetically 45 variation of the refractive index, causing a splitting of the
expressed substances. For example, DsRed and hemoglobin 	 bands at the edge of the Brillouin zone. These stop gaps
are naturally occurring chromophores that have active near- 	 appear as minima in the transmission and give rise to Bragg
infrared absorption and can be used as in vivo, non-invasive	 scattering, which is highly wavelength dependent.
contrast agents. It is possible to introduce or induce over- 	 Delivering the contrast agent to the tissue may be accom-
expression of such chromophores in vivo by genetically 50 plished by a variety of methods. If the target tissue region is a
modifying the experimental animal genome. For example, the 	 relatively large area and can be easily accessed with a hypo-
local expression of DsRed can be achieved either by trans- 	 dermic needle, the contrast agent can be directly injected into
fecting a strong promoter sequence followed by a DsRed 	 the tissue. The contrast agent may then diffuse throughtissues
producing gene, or by enhancing the natural DsRed produc- 	 to create a region of high contrast. In some applications, the
ing mechanism. Examples of other genetically expressed 55 contrast agent can be delivered and targeted by intravenous
absorbing agents include green fluorescent protein (GFP) and 	 injection. This may be useful when examining the circulatory
yellow fluorescent protein (YFP).	 system in tissue, when delivering the contrast agent systemi-
Absorbing agents may be encapsulated prior to delivery to 	 cally, or when the contrast agent is known to aggregate natu-
the tissue. One useful aspect of encapsulation of absorbing 	 rally in some organs or tissues. Examples of these analyses
agents is that non-biocompatible and/or water insoluble 60 include retina angiography and analysis of liver tissue. If cells
absorbing agents can be used. For example, microspheres 	 in the target tissue express specific antigens, delivery of the
containing absorbing agents may be constructed by encapsu- 	 contrast agent may include using a contrast agent conjugated
lating the absorbing agent in one or more layers of bovine	 with antibodies for the antigen. For example, Cy-annexin can
serum protein. See, for example, copending U.S. patent appli-	 be conjugated with a contrast agent for tumor apoptosis stud-
cation Ser. No. 10/463,833 to Suslick et al., filed Jun. 17, 65 ies. Examples of these modified contrast agents include com-
2003, and published as US 2004/0258759 Al; and copending 	 mercially available targeting antibodies labeled with dyes
U.S. patent application Ser. No. 10/463,835 to Boppart et al., 	 specific for the near infrared range.
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Acquiring SOCT data includes dividing low-coherence
radiation between two paths, the reference path and the
sample path. Radiation traveling along the reference path is
reflected against a reference mirror and then collected as a
reference signal. Radiation traveling along the sample path is
reflected against a sample mirror and then into the sample
tissue. Any radiation that is scattered back from the tissue
sample is reflected against the sample mirror and then col-
lected as a sample signal. The signals are filtered to match the
dispersion and polarization and then combined into an inter-
ference pattern. The resulting interference pattern corre-
sponds to the signal from a single point within the sample.
The depth of this point is determined by the distance between
the sample and the light source relative to the distance
between the reference mirror and the light source, as con-
structive interference is maximized for signals having the
same path length. Variation of these relative distances pro-
vides for signals from points at different depths within the
sample. Two-dimensional in-plane translation of the sample
signal relative to the sample can provide signals across a
particular area of the sample.
A variety of techniques can be used to divide the laser
radiation into two signals. For example, the radiation can be
intersected by a partially reflective mirror, reflecting a portion
of the radiation at an angle and permitting the remainder of
the radiation to pass through the mirror. The radiation may
also be passed through a fiber optic assembly that is config-
ured to split the incident radiation into two fiber optic paths.
Variation of the scan depth can be accomplished by moving
the reference mirror and/or the sample along the path of the
radiation. Variation of the lateral position of the scan can be
accomplished by changing the angle of the sample mirror
and/or by moving the sample.
FIG. 3 is a schematic representation of an example of a
device 300 for acquiring SOCT data from a sample 390.
SOCT device 300 includes a low coherence laser source 310,
a fiber optic assembly 320, a reference assembly 330, a
sample assembly 340 and a detector 350. The fiber optic
assembly 320 may include a preliminary beam splitter 322
that diverts 10% of the radiation to adjustable attenuator 324
connected to the detector 350. The fiber optic assembly 320
includes a beam splitter 326 that divides the radiation
between thereference assembly 330 andthe sample assembly
340. The radiation that is reflected from the reference assem-
bly 330 and the sample assembly 340 is directed to the detec-
tor 350. Reference assembly 330 includes reference mirror
332, which may be moved toward or away from the fiber optic
assembly 320. The reference assembly 330 may include fiber
collimator 334, for collection of the radiation reflected from
the reference mirror 332, and may include a dispersion
matching glass 336 to match the dispersion of the reference
signal with the sample signal. The sample assembly 340
includes sample mirror 342, which reflects the radiation to the
sample 390 in the sample holder 344. The orientation of the
sample mirror 342 may be varied to provide for scanning of
the radiation across an area of the sample. In addition to or
instead of changes in the orientation of the sample mirror 342,
the sample holder 344 may be moved along the length and
width of the sample. The sample assembly 340 may include
fiber collimator 346, for collection of the radiation reflected
from the sample mirror 342, and may include a polarization
matching paddle 348 to match the polarization of the sample
signal with the reference signal. The detector 350 can perform
initial processing of the signal to provide the SOCT data.
Initial processing may include digitization, noiseremoval and
digital aberration correction.
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In one example of an SOCT device, the low coherence laser
is a Nd:YVO4 pumped titanium: sapphire source laser that has
• spectrum span from 650 mu to 900 mu after passing through
• non-linear fiber. Dispersion and polarization are matched in
5 the reference and sample assemblies. A precision galvonom-
eter is used to scan the reference mirror, and non-linearities in
galvo speed are relatively small so that interferometric trig-
gering methods are not required. Special fibers, a 3-dB split-
ter, lenses, signal filtering, and demodulation are used to
io support the broad optical and electronic bandwidths. The
detector collects the full fringe data and digitizes the signal
with an oversampling ratio of at least 2.
If the laser source has an ultra-broad spectrum, the imaging
should be done in free space since fiber-optic components
15 typically cannot accommodate the extremely broad spectra. A
spectral domain OCT setup may also be used to improve the
resolution. For applications involving real time analysis, a
real time SOCT based on a field-programmable gate array
(FPGA) implementation can be used. The SOCT sample
20 radiation can be delivered to internal body locations with the
use of fiber-optic probes and catheters.
FIG. 4 represents a method 400 of converting SOCT data
into at least one image that includes performing time-fre-
quency analysis on the data from tissue 410, performing
25 spectral/pattern analysis on the data 420, retrieving the spatial
distribution of the at least one contrast agent in the tissue 430,
and correlating the spatial distribution with at least one dis-
play parameter 440.
Performing time-frequency (TF) analysis on the SOCT
30 interference data 410 can provide advantages over conven-
tional spectral analysis methods, such as the Fourier trans-
form. Conventional methods typically are limited to use with
stationary signals, whereas TF analysis offers localized spec-
tral analysis useful for the non-stationary signals generated
35 by SOCT. Time-frequency analysis in SOCT is described, for
example, in Xu, C. et al. Applied Optics, 44, 1813-1822
(2005).
One aspect of TF analysis is the so-called time-frequency
"uncertainty principle", which recognizes the tradeoff
40 between spectral resolution and time resolution. Optimiza-
tion of this time-frequency resolution may be facilitated by
selection of appropriate TF analysis methods, referred to as
time-frequency distributions (TFDs). For the case of only one
strong scatter within the coherence length, the interferometric
45 power spectrum I(w, z) can be expressed as the multiplication
of source spectrum S(w) and the modulation effect, which
includes the contributions from spectral backscattering pro-
file HS(w), the lumped spectral absorption H,(w) by media
before that scatter, and the total spectral modification HM(w)
so by optical components such as beamsplitter along the optical
pathways. The equation for the interferometric power spec-
trum I(w, z) is:
I(w,z)°S(w)H (w,z)H (w,z)HM(w)
55
Usually S(w) and H_(w) are stationary and known a priori,
therefore measuring I(w,z) offers the opportunity to study the
material properties in the sample.
TFDs for SOCT can be classified into the categories of
60 linear TFDs, Cohen's class TFDs and model-based TFDs.
Linear TFDs are classical time-frequency analysis methods
that only involve linear operations to the time domain signal.
The short-time Fourier transform (STFT) and Gabor repre-
sentations are the most familiar examples. The linear TFDs
65 have the advantage that they are devoid of oscillating cross-
terms, which are present for many other TFDs. Different TF
tradeoffs can be made by choosing different time windows.
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Linear TFDS often lead to good results, but they are compro-
mised by the tradeoff between time and frequency resolution
due to a windowing effect.
Cohen's class TFDS, also referred to as "bilinear TFDS,"
can be performed in many variations. One example of a
Cohen's class TFD is the Wigner-Ville distribution (WVD),
which can achieve better TF resolution than the linear TFDS.
The main drawback with the WVD is the presence of strong
cross-terms if the signal is multi-component. Cross-terms can
be suppressed by using 2-D low-pass filters (kernels) in the
ambiguity domain such as in the smoothed pseudo WVD
(SPWVD). Another example of a Cohen's class TFD is a
data-adaptive TFD that employs a radially-Gaussian kernel
that is signal dependent, and thus changes shape for each
signal (D. L. Jones and T. W. Parks, IEEE Transaction on
Acoustics, Speech and Signal Processing, 38, 2127-2135
(1990)).
In model-based TFDS, the spectrum is not directly calcu-
lated. Instead, models and model parameters are estimated
and used to reconstruct the spectrum. Models should be care-
fully chosen based on prior information. For example, if it is
known that the dominating spectral modification occurring in
a sample is due to the addition of a specific absorbing agent,
a model can be constructed based on the laser spectrum and
the absorbing agent absorption spectrum to extract the
absorbing agent concentration distribution in the sample. If
no prior knowledge is known, an autoregressive-moving
average (ARMA) model is often used. The time localization
of model-based TFDS is achieved by windowing.
The equation for the interferometic power spectrum I(w,
z) includes terms for the contributions from the lumped spec-
tral absorption H,(w) by media before scattering and from the
spectral backscattering profile HS(w). These two contribu-
tions have different requirements on the time-resolution and
frequency-resolution. The spectral back-scattering is a short-
range effect, in that large spectral variations can happen
within a very short distance, usually between interfaces such
as cell or tissue boundaries. High spatial resolution is required
while spectral resolution can be somewhat relaxed because
large spectral modifications are expected. In contrast, the
spectral absorption or scattering loss is a relatively long-range
effect following the Beer's absorption law. At typical
absorber concentrations in tissue, distances larger than the
coherence length of the optical source are typically required
to produce significant spectral modification. Both effects may
co-exist with tissue imaging.
Preferably, the TFD used to perform the TF analysis is
optimized for resolving minute time-frequency variations.
This optimization may include consideration of the various
tradeoffs between different TFDS, the different parameter
choices within TFDS, and the specific SOCT imaging appli-
cation that is being considered.
For example, a comparison can be made between linear
TFDS and Cohen's class TFDS. The linear TFD method
STFT has a simple intuitive interpretation and by choosing
windows of different lengths, different resolution tradeoffs
can be made. Typically, however, one must manipulate the
window depending on whether spectral variation or time
variation are being estimated. For two interfaces that are very
closely spaced, the STFT may be unable to resolve the com-
ponents effectively. In contrast, Cohen's class TFDS typically
can generate more compact TF analysis and therefore are
more appropriate for imaging spectral reflections where
higher time-frequency resolution is desired. However, the
Cohen's-class TFDS suffer from the fact that artifacts are
generated for multi-component signals. This problem may be
mitigated by the fact that many kernel-based TFDS have sig-
10
nificantly-reduced artifact level, and that the SOCT signals
are usually narrow pass-band signals corresponding only to
the laser spectrum used in the experiments. Frequently, the
artifacts from TFDS are out of the pass-band and can therefore
5 easily be removed by filtering.
Continuing this comparison of STFT and Cohen's class
TFDS, the increase in joint time-frequency resolution offered
by Cohen's-class TFDS is not necessarily optimal in all SOCT
10 imaging applications. When imaging tissue absorption or
when using low-concentrations of absorbing agents as con-
trast-enhancing agents, significant absorption frequently
requires a long pathlength. For this case, even the STFT, with
its lower spatial resolution, can be sufficient. Because the
15 STFT is totally devoid of artifacts, this TFD is the most
reliable for such applications. In addition, computing STFT is
significantly faster than other TFDS because of the use of the
fast Fourier transform (FFT). The flexibility of digital pro-
cessing permits essentially arbitrary transformation. One
20 could potentially run a fast and less accurate STFT first,
identify the potential absorbing and spectrally-reflecting
locations, and then run different TFDS in the desired regions
to obtain the best information. When the scattering agents are
very close together and comparable to the coherence length,
25 usual spectral analysis methods may not be reliable, as it may
not be accurate to assume that the frequency components
shown on the TFD plots are actually the frequency compo-
nents representative of that particular spatial point. Instead,
pattern analysis algorithms are better suited for identifying
30 different objects. Digital signal processing algorithms
applied to experimentally-acquired SOCT data may provide
advantages in extracting diagnostic and quantitative informa-
tion.
Performing spectral/pattern analysis on the SOCT interfer-
35 ence data 420 can separate the signal due to the absorbing
agents from the signal due to the scattering agents. Spectral
analysis is based on the difference between the individual
spectral features of the contrast agents and the individual
spectral features of the endogenous material. Pattern analysis
40 is based on the overall spectral profiles of the contrast agents.
For example, the absorbing and/or scattering spectrum of a
contrast agent may have a unique combination (i.e. "pattern")
of modulations and features that can be matched against
known optical profiles. Both spectral analysis and pattern
45 analysis can provide for extraction of useful data regarding
the presence and location of the contrast agents within tissue.
In one example of spectral/pattern analysis, the SOCT data
examined is from a relatively homogenous tissue sample
containing an absorbing agent having a known spectrum. This
50 type of spectral/pattern analysis is described, for example, in
Xu, C. et al. Opt. Express 12, 4790 (2004). The homogeneity
provides for scattering spectra of endogenous scattering
agents that are similar among different tissue layers. The
scattering profile of endogenous scatterers in this case is
55 mostly a linear function. For example, FIG. 5 is a graph of
scattering loss as measured by a spectrometer for a series of
microbead solutions (1% solution of 160 nm silica micro-
beads; 0.5% solution of 330 nm silica microbeads; and 0.5%
solution of 800 nm silica microbeads) and for tissue samples
60 of a thin potato slice and of murine skin. This graph also
includes the absorption attenuation of a 40 µM solution of the
near-infrared dyeADS 830W S (American Dye Sources, Inc.).
All specimens examined showed that scattering loss was lin-
early dependent on wavelength, with correlation coefficients
65 ranging from 0.987 to 0.999. In comparison, the correlation
coefficient for the absorbing agent absorption profile was
measured at 0.202. This spectral difference can be used to
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separate the contribution of the absorbing agent from the
contribution of the scattering agent.
One possible method for separation of the absorbing agent
from the scattering agent in this spectral/pattern analysis is
the "least-squares fitting" algorithm. If the wavelength
dependent factors are eliminated from the interferometric
power spectrum I(w, z) equation, the interference signal may
be expressed as:
P (A , z) ° t (A , z) l t (A , z = 0)
= R'(z)ex+2 J [,,(^, z')+µ (^, z')]dz'}
0
Because the same NIR dye of high absorptivity is used, the
absorption coefficient at certain depths depends only on the
absorbing agent concentration present at that depth. Assum-
ing the scattering agents have similar spectral loss along
sample depth, for the first-order approximation, both µ,(X, z)
and µ (X, z) are separable functions in L and z:
µ'Jk,z)-E=(k)f (z)
where f (z) represents the absorbing agent concentration and
f (z) represents the scattering agent concentration at a par-
ticular depth z. The functions E,(X) and E S(X) represent the
absorption and scattering per unit concentration and per unit
pathlength, and canbemeasuredby a laboratory spectrometer
or by integrating spheres. Substitution of these E(X) expres-
sions into the interference signal expression, followed by
taking the logarithm of both sides yields:
Y (A , z) = log[t'(A , z)]
3
=logR'(z)- 2[£a(A) ff(Z)dz'+£,(^) f f(z')dz']
0	 0
_-£,(;L) a(z)-£s(;L)F(z)+C(z).
Thus, F jz), FS(z), and C(z) are wavelength independent func-
tions to be found. The values of Y(X, z) may be obtained by
time-frequency analysis of the SOCT data.
The Y(X, z) equation typically can only be solved with
some optimality criteria due to the presence of noise and other
non-ideal conditions. In one example, weighted minimal-
mean-square-error (MMSE) optimization provides an unbi-
ased optimization and has minimum-variance properties.
After application of an estimation error variable using a
weighting function that emphasizes the more accurate data,
the least squares solution is:
f 2
-2 (A) W (A) d;L ^z2£s(;L)£a(A)W(A)dA fz2£a(A)W(A)dA
x,
^
z2 £a(;L)£ (t)d;L	 -z2£s(A)W(A)dA	 f z2 £ (l)E(l)d;L










J z2 Y(l, z)£a(;L)W(t;L)d10	






Matrix  is obtained from the SOCT measurements. System
20 matrix A is independent of depth z. Once F jz), FS(z), and
C(z) of matrix X are solved, the absorbing agent concentra-
tion profile f (z) and the scattering agent profile f (z) can be
solved using the definitions:
25
a(z) = 2 f f (z')dz',
0




There are typically two experimental scenarios in SOCT.
The first scenario involves structures that have distinctive
35 layers, such as experiments with cuvettes or layered phan-
toms. For this scenario, the parameters for time-frequency
analysis may be chosen for less time resolution but higher
spectral resolution. Far-spaced distinctive z points may be
40 taken, and the least squares matrix can be solved. The second
scenario involves structures that do not have distinctive lay-
ers, such as biological tissues or inhomogeneous phantoms
without apparent layering. For this scenario, appropriate
time-frequency analysis should be chosen with the param-
45 eters optimized to meet specific needs. Cumulative absorp-
tion F,(z) and scattering FS(z) may be calculated, providing
for retrieval of the absorbing agent profile f (z) and scattering
agent profile f (z).
In another example of spectral/pattern analysis, the SOCT
5o data examined is from a tissue sample containing multiple
scatterers, which may include endogenous scatterers and
exogenous contrast agents. The SOCT analysis may be com-
bined with analysis methods from light scattering spectros-
copy (LSS). This type of spectral/pattern analysis is
55 described, for example, in Xu, C. et al. Opt. Express 13, 5450
(2005), and in Xu et al. Opt. Lett. 31, 1079, (2006). The
imaging volume represented by a voxel in a standard OCT
image is defined by the Gaussian beam width and the coher-
ence gating, centered at the nominal voxel position. The voxel
60 intensity is a coherent sum of scattering from all scatterers
inside the imaging volume. In SOCT, due to the time-fre-
quency uncertainty principle, in order to achieve reasonable
spectral resolution, the imaging volume is usually consider-
ably larger than in standard OCT. The imaging volume in
65 SOCT is defined by the Gaussian beam width and the coher-
ence gating of a particular spectral sub-band (or the time
window length if the STFT is used). Although the imaging
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volume in SOCT is larger than in standard OCT, the single
scattering approximation still holds for most cases.
Assuming all single-scattering events, the collected OCT
signal intensity from N scatterers inside an imaging volume in
the spectral domain is
i
IF(ko)I = IC(ko)I H (ko) .Sn(ko, Pa)
where H is the Fourier transform of the time window,
described as a spatially dependent function h<z>. The func-
tion S(ko,P) represents the field coupled back into the lens,
and is the sample-arm field for the OCT interferometer. Cal-
culating this by integrating the secondary sources over the
collection beam profile, and simplifying due to the use of the
same set of optics for illumination and collection, provides
N
Y,
 Sa (ko, Pa)
n
ff C (ko)Fs(i;)Fi (ia)e`[ra [k;-k,^]R(k;, k_ k_ Pn) F2 k; d 2
where R(k,ks,ko,P„) represents the wavelength-dependent
scattering amplitude of the n-th scatterer located at the origin.
These equations indicate that the scattering-mode SOCT
signal may be obtained from a coherent superposition of the
fields scattered from many plane waves and by many scatter-
ers. In standard LSS, particle size is determined by observing
the spectrum of the scattered field and matching the spectral
signature to a particular particle size. The spectral interfer-
ence arising from the coherent superposition may make such
a procedure complicated for scattering-mode SOCT, since the
measured OCT spectral intensity typically has a modulation
term that depends on the number and the positions of the
scatterers. Algorithms may be used to jointly estimate the
scatterer property and location. In one example, when it is
known a priori that the sample consists of practically identical
particles, many incoherent SOCT measurements may be
averaged. Conventional LSS may perform this incoherent
averaging by using a large beam width and spatially-incoher-
ent light sources. In a second example, an over-sampling
procedure may allow an accurate estimation of particle size
when one expects only one large scatterer surrounded by
many smaller scatterers within the SOCT voxel.
Scatterers may be sized based on the measured spectra. For
example, one approach is based on pitch detection such as
using the Fourier transform or determining the autocorrela-
tion. The principle behind this approach is that the oscillation
"frequency" in the wavelength-dependent scattering is size
dependent, such that larger scatterers tend to produce more
oscillatory patterns. A second approach is based on curve
fitting such as using least-square or c 2 methods. This second
approach provides an exhaustive search of possible scattering
sizes and attempts to fit the normalized experimental mea-
surement to the theoretical prediction.
In many cases, tissue demonstrates layered or regional
structure where adjacent scatterers (either in axial or trans-
verse directions) are more or less homogeneous. If weak
focusing (low NA) is used, the actual single-scatterer spectral
scattering may be resolved by extensive incoherent averag-
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ing. Although OCT is typically referred to as a coherent
high-spatial resolution imaging method, there are several
occasions when incoherent averaging is possible over adja-
cent scan lines. Incoherent averaging is also possible by uti-
5 lizing many so-called "diversity" methods used in OCT
speckle-reduction, such as polarization or angular diversity.
Perhaps the most common SOCT scenario in biological
imaging is that of one large scatterer surrounded by several
small scatterers. For example, cells may have only one
10 nucleus, but may have several mitochondria and multiple
other small scatterers. It is often desirable to resolve the
wavelength-dependent scattering due to the large scatterer in
the presence of these smaller scatterers. For many cases, the
spectrum measured by SOCT in this scenario depends on the
15 exact location of the large scatterer within the imaging beam.
If the large scatterer is in the center of the beam, the scattering
is dominated by the larger scatterer. When the large scatterer
is gradually moved off-center from the central region of the
Gaussian beam, the scattering profile for the large scatterer is
20 gradually corrupted by the modulation effect due to the pres-
ence of the small scatterers. This means that in some cases,
the scattering due to the large scatterer can be resolved by
over-sampling the SOCT signal while transverse scanning,
followed by a computational search for the signal maximum.
25 Retrieving the spatial distribution of the at least one con-
trast agent in the tissue 43 0 includes selecting a parameter that
correlates with the value of the absorbing agent profile or the
scattering agent profile at a given point, followed by quanti-
fying that parameter. Examples of quantifiable parameters
30 include the spectral centroid shift, the Beer's law determina-
tion of spatial distribution, and correlation strength with
expected spectra. These spatial distributions may be retrieved
for some or all of the scanned positions within the tissue.
The spectral centroid of SOCT interference data that has
35 been analyzed by TFD is expressed as:
(' z
H (A , z) = exp - J 2z . µ(;L, z)dz
60
Assuming the spatial analysis window is from z to z , l , then:
a(&), z')d^ = In lHi (&), 
zI)l6 5f^	 H.+ i(
f&)gTFD(w, z) d w
Centroid(z) _40	
Io TFD(, z)dw
The spectral centroid location and its shifting property can be
used as a parameter to characterize the contrast agent distri-
45 bution. For example, if there is a particular absorbing agent in
one location that absorbs preferentially low frequency light,
then the spectral centroid determined by the TFD of the data
from that location will be shifted toward higher frequency.
50 The Beer's law determination of concentration can be
used, assuming that the system can be regarded as a purely
absorbing region that follows Beer's law. The magnitude of
H(w) expressed in wavelength can be written as a function of






Solving this integral equation by stepwise approximation, 	 Example 2
provides a(w,z)dz, which is a quantifiable parameter.
Correlating the spatial distribution with at least one display 	 Absorbing Agent Selection
parameter 440 includes assigning the values measured by the
SOCT data to parameters that can be combined into a single 5	 As noted in Example 1, a diode-pumped mode-locked tita-
display. For example, the two sets of values to be displayed	 nium: sapphire laser source was selected as the optical source,
may be the backscattering intensity, determined by the scat-	 due to its center wavelength around 780 mu. This wavelength,
tering agent profile f (z), and the spatial distribution of the	 and the 120 mu window of the ultrahigh numerical aperture
contrast agent. These values may then be plotted in two- 	 fiber, provided for imaging of tissue due to the transparency
dimensions, corresponding to a plane within the tissue.	 io of most tissue components in this wavelength window.
In one example, an agar phantom sample containing an 	 A near-IR (NIR) absorbing agent was selectedbased onthe
absorbing agent on one side and no absorbing agent on the 	 spectrum of the optical source. The NIR dyeADS7460 (H. W.
other side was imaged by SOCT. FIG. 6 is a schematic rep-	 Sands, Inc.) has a sharp peak at 740 mu. FIG. 7 is a graph of
resentation of the sample, together with a color display of the 	 the emission spectum of the laser (solid line) compared to the
SOCT image. A hue-saturation-luminance color space was 15 absorption spectrum of the absorbing agent (dashed line). As
used to map the backscattering intensity I(x,z) into the satu- 	 shown in FIG. 7, the absorbing agent, when used in appro-
ration parameter and to map the absorbing agent spatial dis- 	 priate concentrations, absorbed the shorter half of the laser
tribution into the hue, keeping the luminance constant. This 	 spectrum wavelengths and transmitted the longer half, pro-
approach permitted the intensity and the spectral parameters 	 ducing a predictable spectral signature. This absorbing agent
of the backscattered light to be visualized in a 2D map. When 20 could also be encapsulated within protein microspheres,
absorbing agent is present, and with increasing depth, the 	 which could be used as delivery vehicles. For example, the
short wavelengths components of the backscattered spectrum 	 absorbing agent could be encapsulated within bovine serum
are more strongly absorbed, giving a red-shift hue for greater 	 albumin microspheres.
depths. When the absorbing agent is not present, no signifi-
cant change is found.	 25	 Example 3
The following examples are provided to illustrate one or
more preferred embodiments of the invention. Numerous	 Characterization of Absorbing Agent
variations can be made to the following examples that lie
within the scope of the invention. 	 Various concentrations of absorbing agent solution con-




were placed in 1-mm thick glass cuvettes (QS-459, Nova




light scattered back from the top and bottom absorbing agent-
glass interfaces were recorded and analyzed to extract the
SOCT Device
	
	 35 spectra. The absorption spectrum of the absorbing agent solu-
tion was obtained using Beer's Law, as outlined by Faber et al
A fiber-based OCT setup was used for these studies. A
	 (D. J. Faber, E. G. Mik, M. C. G. Aalders, and T. G. van
diode-pumped mode-locked titanium: sapphire laser source 	 Leeuwen, Opt. Lett. 28, 1436 (2003)). The centroid of the
with a center wavelength around 780 mu was used as the 	 backreflected light spectrum was calculated in order to dis-
optical source. This laser pumped an ultrahigh numerical 40 play the spectroscopic data in a color image.
aperture (UHNA4, Nufern) fiber to spectrally broaden the 	 FIG. 8 is a graph of the centroid of the backreflected light
output bandwidth to 120 mu. Dispersion and polarization 	 spectrum as a function of the absorbing agent concentration.
were matched in the interferometer arms. A precision linear 	 The dotted curve shows the peak absorption at 740 mu mea-
optical scanner was used to scan the reference arm, and the 	 sured by a spectrometer. The shift of the spectral centroid
small nonlinearity (less than 0.5%) was corrected by calibra-  45 increased and then reached a plateau with increasing absorb-
tion. The axial resolution of this system was measured to be 3 	 ing agent concentration. The increase corresponded well to
µm in air. A high-speed (5 Mega-samples per second, 12-bit) 	 the theoretical calculation based on absorption data. Because
analog-digital converter (NI-PCI-6110, National Instru- 	 OCT typically has penetration depths of 1-2 mm, an absorb-
ments) was used to acquire interferometric fringe data. Axial 	 ing agent concentration of 50 µg/mL could produce the larg-
scans containing the interferometric signals were sampled at 50 est usable shift within this depth. At this concentration, most
100,000 data points, and at 512 transverse positions to form 	 of the spectral center-of-mass shift occured within 1 mm. A
two-dimensional images. 	 further increase in the concentration would limit the penetra-
The collected data were analyzed using Matlab for enve-	 tion depth of SOCT applications, whereas a decrease in the
lope detection and depth-resolved spectroscopic information. 	 concentration would reduce the amount of spectral centroid
Time-frequency analysis was performed using the short-time 55 shift.
Fourier transform (STFT). For experiments in which high 	 An agar sample was prepared with two distinct vertical
depth resolution was not required, a STFT window size of 	 columns separated by a glass wall to prevent diffusion
16,384 points (corresponding to a length of 327 µm in air) was 	 between the columns. One column contained an absorbing
chosen to allow for spectral resolution of 1 mu. For experi- 	 agent concentration of 50 µg/mL, and the other column con-
ments in which both spectral resolution and depth resolution 60 tained no absorbing agent. An equal concentration of 0.2%
were required, the STFT window size was chosen to optimize 	 Intralipid solution was added to both columns for use as a
the time-frequency concentration, typically using 1024 	 scattering agent. The resulting false-color hue-saturation
points (20 µm in air). To increase the signal-to-noise ratio	 SOCT image showed that the spectrum of the backreflected
when recovering the absorbing agent absorption spectrum, 	 light from the column containing the absorbing agent had
the absorption spectra calculated was averaged over 512 mea-  65 shifted toward longer wavelengths with increasing depth,
surements in cases in which lateral resolution was not 	 whereas this effect was negligible for the column without the
required.	 absorbing agent.
US 7,725,169 B2
A stalk of green celery (Apium graveolens var. dulce) was
imagedby SOCT. A celery stalkwas cutnear theroot, leaving
the upper leaves intact to facilitate transpiration. The celery
stalk contained two distinct tissue structures. The bulk of the
stalk was composed of collenchyma tissue, in which most of
the cells were relatively large in size with thickened cell walls
that mechanically supported the stalk. Distributed around the
center of the stalk were vascular bundles in which the cells
were relatively smaller in size and formed conducting vascu-
lar tubes to transport water and nutrients between the roots
and leaves. These tissues were observed using light micros-
copy, as shown in FIG. 9D, in which the vascular bundle is in
the center and is surrounded by collenchyma tissue.
An absorbing agent mixture was prepared by combining 10
mL of a 50 ltg/mL mixture of the NIR dye of Example 2 with
0.5 mL of a 200 ltg/mL mixture of Rhodamine 5G. A control
image of the celery stalk was taken with SOCT before appli-
cation of the absorbing agent. This control image is shown in
FIG. 9B. The root end of the stalk was then submerged in the
absorbing agent mixture for 4 h to allow for capillary trans-
portation. After the absorbing agent mixture had been trans-
ported, the stalk was imaged by SOCT at the same location as
the control image. This contrast enhanced SOCT image is
shown in FIG. 9A. The celery stalk was cut in cross section at
the SOCT imaging location and imaged by fluorescence
microscopy (FIG. 9C) and light microscopy (FIG. 9D). Fluo-
rescence microscopy was permitted by the Rhodamine in the
absorbing agent mixture. The single-photon absorption spec-
trum for Rhodamine was outside of the titanium: sapphire
laser spectrum, and the two-photon absorption and emission
efficiency was extremely low (<10 -10), resulting in no detect-
able contribution to the SOCT signal.
When imaged by SOCT without an absorbing agent, no
significant difference in the spectral center of mass was
observed between the two types of tissues. The contrast
between the two tissues was enhanced by the presence of the
NIR absorbing agent. This contrast enhancement was appar-
ent in the vascular regions containing the NIR absorbing
agent, where strong shifting of the spectral centroid occurred.
In FIG. 9A, the color bar represents the correspondence
between pseudocolor labeling and the spectral centroid shift
in the image. The surrounding avascular collenchyma tissue
showed minimal changes. The vascular bundle region show-
ing strong SOCT contrast enhancement also correlated well
with the region showing strong fluorescence (FIG. 9C).
Example 5
Comparison of TFD Performance on Simulated
SOCT Signals
Synthetic signals were generated in order to produce a
comprehensive class of SOCT-like signals controlled by sev-
eral parameters. Their design was based on the equation for
the interferometric power spectrum I(w, z):
I(w,z)°S(w)H (w,z)g (w,z)H (w)
To simplify the simulation parameters, the sampling time and
reference arm translation speed were adjusted such that the
800 mu laser wavelength corresponded to a digital frequency
of 0.125 Hz. Axial depth was converted to a signal acquisition
time from 0 sec to I sec. Although an experimental OCT
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system would acquire axial scans much faster, these numeri-
cally-simple parameters were used without losing theoretical
generalities.
5 Three different imaging scenarios were considered. Thefirst scenario was a Gaussian pulse with a spectrum centered
at 800 mu and a FWHM of 100 mu. This synthetic signal
corresponded to a typical SOCT signal from a perfectly-
reflecting mirror, and was used for testing TFD performance
10 on minimal time-frequency spread. The second scenario was
two consecutive "spectrally absorbed" Gaussian pulses, in
which the first pulse contained all of the frequencies of the
optical source, and the second pulse contained only the lower
half of the frequencies of the optical source. This scenario
15 corresponded to two closely-spaced reflecting interfaces with
different spectral reflection profiles. By varying the distance
between the pulses, this scenario was used for testing the
minimal spatial separation of TFDs given a prior requirement
on frequency resolution. The third scenario was a consecutive
20 Gaussian pulse sequence with random positioning and a
slowly varying spectrum between pulses, representing a
region of homogeneous absorption and scattering. The
absorbing agents were assumed to uniformly absorb upper
25 half frequencies, following Beer's law. This sequence corre-
sponded to SOCT signals scattering back from tissue with a
roughly uniform scattering agent distribution but with high
absorbing agent concentrations, and was used for testing the
ability of the TFDs to retrieve the absorption coefficient of the
30 media.
The synthetic signals were subjected to TF analysis using
different TFDs. The TFDs of the signal on the TF plane were
generated as color-scale images. In the cases where the dis-
tribution has negative or complex values, the magnitude was
35 taken. For each of the TFDs, parameters were optimized by
extensive parameter searching to represent the best possible
outcome using that type of TFD. In cases in which good
criteria were difficult to obtain, such as when lowering the
40 cross-terms compromised the resolution of the auto term,qualitative evaluation was used to produce the best analysis.
To compare the overall quality of the TFDs on the synthetic
signal from the first scenario, two criteria were used. The first
criterion was the time-frequency spread (by measuring stan-
45 dard deviation) of the TFDs. The second criterion computed







which is the fourth power of the L4 norm divided by the
squared Lz norm of the magnitude of the TFD. See D. L. Jones
and T. W. Parks, IEEE Transaction on Acoustics, Speech and
Signal Processing, 38, 2127-2135 (1990). The testing results
60 of TFDs on this synthetic signal are listed in Table 1. The
linear TFD examined was the STFT with a Hamming window
("STFT"); the Cohen's class TFDs examined were WVD and
Morlet wavelet ("WT"); and a Gaussian model was used for
the model-based TFD ("Model-based"). The WVD achieved
65 the best time-frequency concentration. Because signal model
was exactly known for synthetic signal, model based TFD
completely recovered the ideal TFD.
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TABLE I	 TABLE 3
TF resolution of TFDs on synthetic signal from first imaging scenario
Ideal	 Model-
TFD	 STFT WT WVD based
Time spread (s) 0.027 0.032 0.040 0.020 0.027
Frequency spread (Hz) 0.016 0.032 0.038 0.022 0.017
Time-frequency 4.32 10.2 15.2 4.40 4.59
product (10-4)
Concentration 250 102 132 305 250
To compare the overall quality of the TFDs on the synthetic
signal from the second scenario, two neighboring scattering
agents were considered to be distinct in SOCT if the maxi-
mum shift of the spectral centroid was at least half that of what
the shift would be if the scattering agent was alone. The linear
TFD examined was the STFT with a Hamming window
("STFT"); the Cohen's class TFDs examined were SPWVD
and Morlet wavelet ("WT"); and Ideal LPFs and HPFs were
used for the model-based TFDs ("Model-based"). Simple
W VD did not perform well under thi s situation because of the
strong cross-terms. Instead, the smoothed pseudo-Wigner-
Villie distribution (SPWVD) was used with a smoothing
Gaussian kernel applied independently in the time and fre-
quency direction. The minimal distances needed for different
TFDs to discriminate the two pulses are listed in Table 2. For
reference, the structural OCT resolution (by FWHM crite-
rion) is also listed in Table 2. The Cohen's-class TFDs had
better performance than the STFT on this synthetic signal.
TABLE 2
TF resolution of TFDs on synthetic signal from second imaging scenario
Structural	 Model-
OCT Ideal TFD STFT WT SPWVD based
Minimal	 0.053	 0.025	 0.036 0.039	 0.033	 0.026
distance (s)
To compare the overall quality of the TFDs on the synthetic
signal from the third scenario, the absorption was assumed to
follow Beer's Law. The locations of the scattering agents
were first identified by peak detection. Then, absorption spec-
tra were determined from TFDs based on least-square curve
fitting of TFDs from multiple scattering agents. The error
function was calculated from the measured absorption spec-




The "Frequency Band" was defined by the 10% level crite-
rion. The linear TFD examined was the STFT with a Ham-
ming window ("STFT"); the Cohen's class TFDs examined
were SPWVD and Morlet wavelet ("WT"); and Ideal LPFs
were used for the model-based TFDs ("Model-based"). The
errors for different TFDs are listed in Table 3. The model-
based TFD out-performed all other TFDs. Linear TFDs were
reasonably good, while all Cohen's-class TFDs gave errone-
ous outcomes due to cross-terms and non-ideal smoothing
operations.
TF resolution of TFDs on synthetic signal from third imaging scenario
5	 Ideal	 Model-
TFD	 STFT	 WT	 SPWVD	 based
Error	 0.0%	 —5.0%	 —6.1%	 34.3%	 0.0%
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Example 6
Comparison of TFD Performance on Experimental
SOCT Signal of Two Closely-Spaced Reflecting
15	 Interfaces
Experimental SOCT signals were obtained that corre-
sponded to the second imaging scenario in Example 5. A
sample was constructed to provide two back-scattering inter-
20 faces that were spatially close and that exhibited different
back-scattering spectra. Double-sided tape having a thick-
ness of approximately 80 µm was placed between and along
one edge of two 24x60 mm glass coverslips. A paper clip
compressed the coverslips at the opposite edge to make a
25 semi-closed thin gap between the two coverslips. The assem-
bly was then turned vertically and one wedge-shaped open
side was submerged into a shallow 20 mg/ml solution of the
near-infrared dye of Example 2. After a few seconds, the
absorbing agent solution filled the wedge-shaped space
30 between the coverslips via capillary forces. Unlike many
other water-soluble NIR absorbing agents, this dye strictly
followed the Beer's Law of absorption up to very high con-
centrations. Even at 20 mg/ml, the absorbing agent still main-
tained its expected absorption spectrum. No photobleaching
35 effect was observed with 10 mW of focused laser power over
a period of 10 minutes.
The sample was imaged with a fiber-based OCT setup
similar to the device of Example 1, but with the following
modifications. A thin lens with a 40 mm focal length was used
40 to minimize the effect of chromatic aberration, dispersion,
and focusing. Non-linearities in the reference scanning rate
were accounted for by acquiring a reference fringe pattern
using a narrowband laser diode with a center wavelength
around 776 nm and a bandwidth of I nm, and applying a data
45 correction algorithm. This OCT system provided 4 µm axial
resolution, with  3.2 mm depth of focus (confocal parameter)
in air. The interference was detected using an auto-balancing
detector (Model 2007, New Focus, Inc.). The signal was
amplified and filtered using an anti-aliasing low-pass filtered
50 in a custom analog circuit. Before applying TFD analysis, the
signal was bandpass filtered to remove excessive noise in the
digital domain and was digitally corrected for dispersion.
Axial scans along different wedge positions (different
absorbing agent thicknesses) were acquired. The sample was
55 placed on an angle-adjustable stage such that the light
reflected back from the glass/liquid interfaces was in a near-
normal direction. The incident laser power was attenuated to
prevent saturation at the photodetector. The interference
fringe data were collected for analysis with different TFDs.
6o The interference fringes resulting from multiple reflections
(light bouncing back and forth between the two glass inter-
faces) were found have magnitudes at least 50 times smaller
than the main interference fringes, and therefore were not
used in our analysis.
65 The windows chosen for the STFT were Hamming win-
dows of length corresponding to one coherence length of the





in terms of coherence lengths was measured by counting the
number of fringe peaks between two pulse centers and the
number of fringe peaks between the FWHM from a single
pulse off of a mirror. Most of the shorter wavelengths were
absent from the light reflected from the lower absorbing
agent/glass interface because of the absorbing agent absorp-
tion. Blurring of the time-frequency representation as the
separation of the two interfaces narrowed was observed, as
would be expected from the "uncertainty principle". Specifi-
cally, when the distance between the two interfaces was less
than the coherence length of the optical source, it became
difficult to resolve them.
The experimental signals were subjected to TF analysis
using different TFDs to compare the resolving power of the
TFDs in this setting. The STFT, Scalogram, Choi-William
distribution, and model-based TFDs were examined. The
length of time windowing for the STFT and the Choi-William
distribution was chosen to correspond to 1 µm in air. This
length offered the best separation by qualitative assessment.
Morlet wavelets were chosen for the Scalogram. The model
for the model-based TFD was set up by assuming that the
TFD of the pulse from the first interface was the same as the
WVD of a pulse from a mirror (TFDM(z,I)) except for a
scaling factor, and that the TFD of the pulse from the second
interface was the first TFD after absorbing agent absorption
multiplied by another scaling factor:
TFD=AxzFDM(z ,k)+TFDM(z-z^,)exp(—BxE(k))
whereA and B were the scaling factors and z t was the distance
between two interfaces. This equation was digitized in z and
X to have each z point represent 0.1 µm and each X point
represent 1 mu. The term e(I) representing absorbing agent
absorptivity was measured by a spectrometer. Spline interpo-
lations were used whenever the experimentally measured
data had different data points from the model. The criterion
for model optimization was to search for the best A, B, and z,
such that the lowest mean-square-error between the model
TFD and the TFD by STFT was generated. Because it was
computationally-expensive to search for three optimal
parameters (A, B, z,) in 3-D space, z, was first determined
based on the fringe number. The parameters A and B were
only searched for their optimal values in 2-D space, and then
the optimal z, was determined for that A and B. The two-step
recursion was repeated until results stabilized.
The TFDs from Cohen's class (the Choi-William distribu-
tion and Scalogram) had comparative performance, while
both performed better than the STFT Artifacts in the TFD
plots for the Choi-William distribution were due to the cross-
terms during the bilinear transformation of the signal. How-
ever, because the cross-terms were out of the primary signal
bands, they could be rejected easily. Confirming the results of
the simulation of Example 5, the model-based TFD had the
best performance in terms of sharpness, although it may or
may not have represented the true TFD.
Example 7
Comparison of TFD Performance on Experimental
SOCT Signal of Homogeneous Media Containing
Small Number of Scattering Agents
Experimental SOCT signals were obtained that corre-
sponded to the third imaging scenario in Example 5. Phantom
samples were prepared in liquid form to provide homoge-
neous media containing a small amount of scattering agents.
The near-infrared dye ADS830WS (American Dye Sources,
Inc.) was used. Unlike the absorbing agent SDA7460 used in
Example 6, this dye had a sharp absorption peak around 810
mu, which was close to the emission spectrum of the laser
source. Having an absorption peak near the center of the laser
5 source spectrum facilitated the evaluation of the performance
of different TFDs. When dissolved in methanol, this absorb-
ing agent was also very stable and did not show any pho-
tobleaching effect under 10 mW of focused laser power over
a period of 10 minutes. Silica microbeads 0.33 Min diameter
io (Bang Laboratories, Inc.) were used as scattering agents. The
solution containing the absorbing agent and microbeads was
placed inside a thin glass cuvette and imaged with the SOCT
setup of Example 6. The concentrations of the absorbing
agent and silica microbeads were adjusted such that the
15 absorption loss was 5 times larger than the scattering loss at
800 mu.
Prior to SOCT imaging, the mixture was measured by a
spectrometer for the combined effect of absorption loss and
scattering loss. The absorption spectra were retrieved by each
20 TFD method similar to the analysis on the third synthetic
signal in Example 5, except for three additional modifica-
tions. First, a control sample containing the same concentra-
tion of microbeads, but without absorbing agent, was used for
data-correction to reduce the system error. Second, because
25 very closely-spaced scattering agents exhibit a significant
spectral-interference effect, averaging of TFDs from 512 scan
lines was performed to obtain the final TFDs. Third, because
of the large number of data points collected (50,000 points/
scan line), it was not possible to perform different TFDs
3o directly without significant computational complexity.
Therefore, taking advantage of the fact that the SOCT signals
were narrow pass-band signals, data were demodulated and
decimated to obtain the shortest possible analytic signals
without losing frequency information within the laser source
35 spectrum. The time window sizes forthe STFT, Choi-William
distributions and the model based TFDs were chosen to be
four coherence length. The Morlet wavelet was used for the
wavelet transform. Because no prior information was
assumed, an autoregressive (AR) model using the Burg
40 method was used for the model-based TFDs, with a model
order set to 4.
The absorption spectra obtained by different TFDs are
shown in FIG. 10, together with the spectral range of the laser
(F WHM). For comparison, each spectra was normalized to its
45 respective peak value. In this SOCT imaging scenario, the
STFT and the wavelet transform were the reliable methods.
The model-based TFD had reasonably good performance
even though no assumption was made when constructing the
model. The spectrum retrieved using the Choi-William TFD
50 was totally random. These results confirm the predictions of
the simulation of Example 5.
Example 8
55	 Spectroscopic Spectral-Domain OCT Imaging
A custom-designed and constructed multi-modality micro-
scope was used in this study, which enabled not only OCT and
SOCT, but also simultaneous multi-photon microscopy using
60 the same optical source. The light source consisted of a fre-
quency-doubled Nd:YVO4 pumped Ti:sapphire laser with a
center wavelength of 800 mu, a bandwidth of 40 mu, and an
80 MHz pulse repetition rate. This source was used as both a
low-coherence source for OCT and also as an excitation
65 source for multi-photon microscopy. The microscope objec-
tive (20x, 0.95 NA, water immersion, Olympus) had a high





confinement of the backscattered OCT signal. Dispersion in
the proprietary glass of the objective was balanced digitally in
the acquired image data. The interferometric setup was simi-
lar to those used in spectral-domain OCT. In our configura-
tion, a free-space 50150 beam splitter was used. The light in
the detection arm was collimated and dispersed off a blazed
diffraction grating having 830.3 grooves per millimeter. The
optical spectrum was focused on a line-scan camera (L104k-
2k, Basler, Inc.) which contained a 2048-element CCD array
of detection elements with a maximum readout rate of 29
kHz. Digital processing of the detected signal included a
Spline interpolation to make the signal more uniform, and a
discrete Fourier transform on each set of 2048, 10-bit, values
captured by the CCD to transform the signal from the fre-
quency (spectral) domain into the spatial (depth) domain.
The axial PSF of the objective using spectral-domain OCT
detection (coherence-gating) was measured to be 2.2 µm at
FWHM. Because the source spectrum was roughly Gaussian,
the sensitivity of OCT to the retro-reflected light decreased
exponentially with axial distance. Note that in this system the
confocal gating (confocal parameter=2.2 µm) was below the
coherence gating (coherence length-7 µm) with the laser
source bandwidth of 40 mu. OCT images of a calibrated U.S.
Air Force test target were used to determine the high trans-
versal resolution of this system. By use of the edge-scan
definition, a transverse resolution of less than 0.9 µm was
measured. To determine the sensitivity of the system, the
OCT PSF from a mirror translated through the focal plane
was measured with calibrated attenuation filters inserted in
the sample arm. The SNR was calculated by taking the ratio
between the signal power and the noise variance. With 1 mW
(0 dBm) of power incident on the mirror, the measured SNR
was found to be equal to 97 dB. The dynamic range within
experimental image data was approximately 60 dB. Cali-
brated fluorescent microbeads were used to determine the
axial and transverse multi-photon microscopy resolutions of
our system, which were 0.8 M and 0.5 µm, respectively.
Incident optical power ranged from 1-5 mW (1 mW typical),
with the higher power used to excite two-photon fluorescence
from green-fluorescent protein (GFP).
The spectral-domain OCT interference fringes were
acquired at 2048 pixels per OCT point, covering a potential
full-array light spectral range from 740 nm to 860 mu, and
which corresponded to an imaging depth of approximately
2.7 mm in air. The raw spectral-domain OCT interference was
given by:
I(kz)_, 21R,R,(kz)_J"2S(k)cos(2kAp)
where k is the free-space wave number, z is the depth, R,, and
RS are the reference reflectivity and sample reflectivity,
respectively, S(k) is the source spectral density, and Dp is the
optical pathlength difference at zo that is defined by the focal
gating of the high NA objective. The reference reflectivity R,,
was assumed to be wavelength-independent. The modulation
transfer function of the spectral-domain OCT system was
calibrated using a mirror, and the raw spectral domain signal
was re-mapped to k space using cubic Spline interpolation.
The spectral-domain data then was demodulated to baseband
by first taking the fast Fourier transform (FFT) to obtain the
depth-dependent analytical signal, followed by the inverse
FFT of the depth signal segment centered around the focal
gate position. A Gaussian window of 512 points with a
FWHM of 256 points was used, which corresponded to a
spectral resolution of 0.5 mu.
The retrieved R,9(k) at the focal plane of the OCT objective
was processed by two different SOCT analysis methods. The
first method was based on metameric imaging, where the
scattering spectrum is divided into different sub-spectral
bands. The signal intensity in each sub-spectral band was
integrated to produce the intensity for one color channel. For
5 this study, the window within the FWHM of the source spec-
trum was divided into three equally spaced sub-bands, and the
intensity from the low-, mid-, and high-frequency bands were
assigned to the red, green, and blue channels, respectively.
This method represented similar information as the tradi-
io tional spectral centroid method, but was more robust and
more similar to the mechanism of human vision. The second
method was based on spectral analysis initially proposed in
LSS. The back-scattered spectra were first analyzed by the
FFT, and the first peak of the FFT data was used for hue
15 information in an HSV color scale. This peak position was
related to the physical size and inter-scatterer distance of the
dominant scatterers, such as the nucleus, within the focal gate
at that location. The metameric method was more qualitative
and suited for attenuation-based measurements in SOCT,
20 while the spectral analysis method used in LSS was more
quantitative and suited for scattering-based measurements in
SOCT. These representative SOCT analysis methods were
performed on spectral-domain OCT data collected from tis-
sue and cell specimens imaged using our multi-modality
25 microscope.
FIG. 11 shows image-data acquired from mammary tissue
of a rat, consisting of adjacent adipose (fat) and muscle tissue.
FIG. 11B is a histological image of the tissue. The high-
resolution OCT image showed individual adipocytes in the
30 center of the image (FIG. 11A), but exhibited regions of low
backscatter over the more dense muscle tissue at the upper
right and lower left corners of the image, possibly due to
forward scattering or polarization-dependent effects. How-
ever, compared to OCT, the SOCT analysis methods (FIGS.
35 11C and 11D, respectively) showed increased contrast for
muscle compared to the adipose tissue where there was suf-
ficient backscattered signal for spectral analysis. This con-
trast enhancement (light yellow and blue regions in FIG. 11C,
and green and blue regions in FIG. 11D) was due to different
40 scatterer sizes and scatterer organization (likely nuclei and
other organelles), and was more prominent in the SOCT
image based on LSS spectral analysis (FIG. 11D, green
regions), which has been shown to detect changes in nuclear
regions.
45 FIG. 12 shows an OCT image of live fibroblast cells in
culture, and the corresponding SOCT image using LSS spec-
tral analysis (FIGS. 12A and 12B, respectively). The first
peak-positions of the FFT obtained from the modulation pat-
terns of the back-scattered light were clearly different near the
50 center of the cell, compared to the periphery of the cell. One
possible reason for this difference was the presence a large
scatterer, the nucleus, located nearthe center of these cultured
cells. These SOCT findings were confirmed by multi-photon
imaging of this cell culture, using the simultaneous multi-
55 modality capabilities of the microscope. These transfected
fibroblasts expressed GFP-labeled vinculin (a cell adhesion
protein) and were co-labeled with a DNA-specific dye (Ho-
echst 33342) for localization of nuclei relative to the sur-
rounding cell structures (FIG. 12C). The simultaneous multi-
60 modality imaging afforded by the microscope enabled
overlays of various image channels, as shown for OCT and
the multi-photon fluorescence from the DNA/nuclear dye
(FIG. 12D). The SOCT analysis information was consistent
with the multi-photon imaging data in identifying the loca-
65 tions of the nuclei within these cells. Of the six nuclei iden-
tified in the multi-photon fluorescence image (FIG. 12C), five
nuclei were clearly identified in the SOCT image (FIG. 12B,
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green/blue regions). The remaining cell nucleus (left-most
cell) may not be identified as clearly with SOCT because this
cell may have been smaller and had a flatter profile than the
others, resulting in a backscattering spectrum more similar to
the background.	 5
In conclusion, spectroscopic spectral-domain OCT analy-
sis with tight focal gating decoupled the inherent trade-off
between spectral and spatial (depth) resolution. This enabled
the extraction of more minute spectroscopic features from
within the small imaging volumes, making localized analysis io
of wavelength-dependent scattering possible. Wavelength-
dependent scattering and the resulting spectral modulation
were information-rich processes that were dependent on both
optical properties of the scatterer and the inter-scatterer spac-
ing. Spectroscopic spectral-domain OCT was capable of 15
enhancing contrast invarious tissues and cells based solely on
endogenous structures.
While various embodiments of the invention have been
described, it will be apparent to those of ordinary skill in the
art that other embodiments and implementations are possible 20
within the scope of the invention. Accordingly, the invention
is not to be restricted except in light of the attached claims and
their equivalents.
What is claimed is:
1. A method of forming an image of tissue, comprising:
selecting at least one contrast agent, comprising at least one
water-soluble, biocompatible absorbing agent having an
absorption profile;
delivering the contrast agent to the tissue;
acquiring spectroscopic optical coherence tomography
data from the tissue across a spectrum range,
wherein the acquiring does not change the absorption pro-
file of the absorbing agent; and
converting the spectroscopic optical coherence tomogra-
phy data into at least one image,
wherein the at least one absorbing agent absorbs in the
near-infrared region,
the absorption profile of the absorbing agent is sharp, and
the absorbing agent is highly absorbing in a first portion of
the spectrum range and has little to no absorption in a
second portion of the spectrum range.
2. The method of claim 1, wherein the at least one contrast
agent further comprises at least one scattering agent.
3. The method of claim 1, wherein the selecting at least one
contrast agent comprises:
determining the optical window of the tissue;
selecting a laser spectrum range that is within the optical
window; and
selecting at least one absorbing agent that absorbs within
the laser spectrum range.
4. The method of claim 3, wherein the selecting at least one
absorbing agent comprises selecting at least one absorbing
agent having an absorbance spectrum that overlaps the laser
spectrum range.
5. The method of claim 3, wherein the selecting at least one
absorbing agent further comprises selecting at least one
absorbing agent that can be delivered to the tissue.
6. The method of claim 3, further comprising selecting at
least one scattering agent that scatters within the laser spec-
trum range.
7. The method of claim 6, wherein the selecting at least one
scattering agent further comprises selecting at least one scat-
tering agent that can be delivered to the tissue.
8. The method of claim 1, wherein the converting of the
spectroscopic optical coherence tomography data into at least
one image comprises:
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performing time-frequency analysis on the data;
performing spectral/pattern analysis on the data;
retrieving the spatial distribution of the at least one contrast
agent in the tissue; and
correlating the spatial distribution with at least one display
parameter.
9. The method of claim 8, wherein the at least one contrast
agent further comprises at least one scattering agent,
the retrieving comprises retrieving the spatial distributions
of the at least one absorbing agent and of the at least one
scattering agent, and
the correlating comprises correlating the spatial distribu-
tions of the least one absorbing agent and of the at least
one scattering agent with at least one display parameter.
10. The method of claim 1, wherein the tissue is living.
11. A method of forming an image of tissue, comprising:
selecting a laser spectrum range that is within an optical
window;
selecting at least one water-soluble, biocompatible absorb-
ing agent having an absorption profile, the absorbing
agent absorbing within the laser spectrum range;
selecting at least one scattering agent that scatters within
the laser spectrum range;
delivering the at least one absorbing agent and the at least
one scattering agent to the living tissue;
acquiring spectroscopic optical coherence tomography
data from the living tissue across the spectrum range,
wherein the acquiring does not change the absorption pro-
file of the absorbing agent;
performing time-frequency analysis on the data;
performing spectral/pattern analysis on the data;
retrieving the spatial distributions of the at least one
absorbing agent and of the at least one scattering agent in
the living tissue; and
correlating the spatial distributions with at least one dis-
play parameter, wherein the at least one absorbing agent
absorbs in the near-infrared region,
the absorption profile of the absorbing agent is sharp, and
the absorbing agent is highly absorbing in a first portion of
the spectrum range and has little to no absorption in a
second portion of the spectrum range.
12. A method of converting spectroscopic optical coher-
ence tomography data into at least one image, comprising:
performing time-frequency analysis on spectroscopic opti-
cal coherence tomography data from tissue;
performing spectral/pattern analysis on the spectroscopic
optical coherence tomography data;
retrieving the spatial distribution of at least one contrast
agent in the tissue; and
correlating the spatial distribution with at least one display
parameter,
wherein the at least one contrast agent comprises at least
one absorbing agent having an absorption profile,
the acquiring does not change the absorption profile of the
absorbing agent,
spectroscopic optical coherence tomography data is
acquired across a spectrum range,









60	 the absorption profile of the absorbing agent is sharp, and
the absorbing agent is highly absorbing in a first portion of
the spectrum range and has little to no absorption in a
second portion of the spectrum range.
13. The method of claim 12, wherein the at least one
65 contrast agent comprises at least one scattering agent.
14. The method of claim 12, wherein the at least one
contrast agent further comprises at least one scattering agent,
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the retrieving comprises retrieving the spatial distributions
of the at least one absorbing agent and of the at least one
scattering agent, and
the correlating comprises correlating the spatial distribu-
tions of the least one absorbing agent and of the at least
one scattering agent with at least one display parameter.
15. A method of analyzing tissue, comprising:
delivering at least one contrast agent comprising at least
one absorbing agent having an absorption profile, to the
tissue; and
acquiring spectroscopic optical coherence tomography
data from the tissue across a spectrum range,
wherein the acquiring does not change the absorption pro-
file of the absorbing agent,
the absorption profile of the absorbing agent is sharp, and
the absorbing agent is highly absorbing in a first portion of
the spectrum range and has little to no absorption in a
second portion of the spectrum range.
16. A method of forming an image of tissue, comprising:
delivering at least one contrast agent comprising at least
one absorbing agent having an absorption profile, to the
tissue;
acquiring spectroscopic optical coherence tomography
data from the tissue across a spectrum range,
wherein the acquiring does not change the absorption pro-
file of the absorbing agent;
separating the signal due to absorption from the signal due
to scattering; and
converting the spectroscopic optical coherence tomogra-
phy data into at least one image,
wherein the absorption profile of the absorbing agent is
sharp, and
the absorbing agent is highly absorbing in a first portion of
the spectrum range and has little to no absorption in a
second portion of the spectrum range.
17. The method of claim 16, wherein the at least one
contrast agent further comprises at least one scattering agent.
18. The method of claim 16, wherein the converting the
spectroscopic optical coherence tomography data into at least
one image comprises:
performing time-frequency analysis on the data;
performing spectral/pattern analysis on the data;
retrieving the spatial distribution of the at least one contrast
agent in the tissue; and
28
correlating the spatial distribution with at least one display
parameter.
19. The method of claim 18, wherein the at least one
contrast agent further comprises at least one scattering agent,
5 the retrieving comprises retrieving the spatial distributions
of the at least one absorbing agent and of the at least one
scattering agent, and
the correlating comprises correlating the spatial distribu-
tions of the least one absorbing agent and of the at least
10	 one scattering agent with at least one display parameter.
20. The method of claim 16, wherein the tissue is living.
21. A method of converting spectroscopic optical coher-
ence tomography data into at least one image, comprising:
performing time-frequency analysis on spectroscopic opti-
15	 cal coherence tomography data from tissue;
performing spectral/pattern analysis on the spectroscopic
optical coherence tomography data;
retrieving the spatial distribution of at least one contrast
agent comprising at least one absorbing agent having an
20	 absorption profile, in the tissue; and
correlating the spatial distribution with at least one display
parameter;
wherein the performing spectral/pattern analysis on the
spectroscopic optical coherence tomography data com-
25	 prises separating the signal due to absorption from the
signal due to scattering,
the spectroscopic optical coherence tomography data is
acquired across a spectrum range without changing the
absorption profile of the absorbing agent,
30	 the absorption profile of the absorbing agent is sharp, and
the absorbing agent is highly absorbing in a first portion of
the spectrum range and has little to no absorption in a
second portion of the spectrum range.
22. The method of claim 21, wherein the at least one
35 contrast agent comprises at least one scattering agent.
23. The method of claim 21, wherein the at least one
contrast agent further comprises at least one scattering agent,
the retrieving comprises retrieving the spatial distributions
of the at least one absorbing agent and of the at least one
40	 scattering agent, and
the correlating comprises correlating the spatial distribu-
tions of the least one absorbing agent and of the at least
one scattering agent with at least one display parameter.
